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The major causative agent of tuberculosis (TB), i.e., Mycobacterium tuberculosis (Mtb),
has developed mechanisms to evade host defense responses and persist within host cells
for prolonged periods of time. Mtb is also increasingly resistant to existing anti-TB drugs.
There is therefore an urgent need to develop new therapeutics for TB and host directed
therapies (HDTs) hold potential as effective therapeutics for TB. There is growing interest in
the induction of autophagy inMtb host cells using autophagy inducing compounds (AICs).
Nanoparticles (NPs) can enhance the effect of AICs, thus improving stability, enabling cell
targeting and providing opportunities for multimodal therapy. In this review, we focus on
the macrophage responses to Mtb infection, in particular, the mechanistic aspects of
autophagy and the evasion of autophagy by intracellularMtb. Due to the overlap between
the onset of autophagy and apoptosis; we also focus on the relationship between
apoptosis and autophagy. We will also review known AICs in the context of Mtb
infection. Finally, we discuss the applications of NPs in inducing autophagy with the
intention of sharing insights to encourage further research and development of
nanomedicine HDTs for TB therapy.
Keywords: Mycobacterium tuberculosis, innate immunity, autophagy and tuberculosis, host directed therapies,
immunotherapeutic nanoparticles, xenophagy, LC3-associated phagocytosis, apoptosis and tuberculosisINTRODUCTION
TB caused by an infection from the bacillusMycobacterium tuberculosis (Mtb) is among the top ten
leading causes of death globally, and is the main cause of death from a single infectious agent. An
estimated 1.7 billion people across the world are infected with Mtb and in 2018, approximately 10
million new cases were reported, corresponding to 130 cases per 100,000 population (World Health
Organization, 2019). Geographically, the majority of TB cases are found mostly in South-East Asia,
Africa, and the Western Pacific. The eight countries; India, China, Indonesia, the Philippines,gy | www.frontiersin.org February 2021 | Volume 10 | Article 6184141
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thirds of all cases globally (World Health Organization, 2019).
TB commonly affects the lungs, where it is called pulmonary
TB (PTB) but can also affect other organs throughout the body
and in this case; it is known as extra-pulmonary TB (EPTB)
(World Health Organization, 2018). It is estimated that between
5 and 15% of the estimated 1.7 billion people (about 20% of the
world population) is infected with Mtb will develop TB during
their lifetime (World Health Organization, 2018). However, the
probability of developing TB is greater for people living with HIV
and also higher for people who smoke, consume alcohol, have
diabetes, and/or are under-nourished (World Health
Organization, 2019). The current drug therapy for TB is a six-
month regimen that consists of a two month intensive phase,
where patients receive four first-line antibiotics [i.e., ethambutol
hydrochloride (EMB), isoniazid (INH), rifampicin (RIF), and
pyrazinamide (PZA)], followed by a four month continuous
phase, where patients receive RIF and INH (Grange and Zumla,
2002; Nasiruddin et al., 2017; Bekale et al., 2018).
The lengthy multidrug therapy has been shown to overwhelm
patients with high pill load and toxic side effects, resulting in a
considerable reduction inpatient compliance and adherence to
the medication (Dartois, 2014). This therefore increases the
potential risk for the development of drug-resistant strains in
noncompliant patients (Kimmey and Stallings, 2016; Kaufmann
et al., 2018). As a result, drug-resistant TB remains a major
public health hazard. In 2018, approximately 500,000 new cases
of RIF-resistant TB (RR-TB) (of which 78% had multidrug-
resistant TB) were reported (World Health Organization, 2019).
India, China and the Russian Federation were found to be the
three countries with the largest share of the global burden of RR-
TB, with each having 27%, 14% and 9%, respectively. In addition,
18% of treated cases in 2018, were either multidrug-resistant TB
(MDR-TB) or RIF-resistant TB (RR-TB), with the highest
proportions (>50%) of these cases being in countries of the
former Soviet Union (World Health Organization, 2019). MDR-
TB plus resistance to at least one of the fluoroquinolones and
one of the injectable agents used in MDR-TB treatment regimens
is known as extensively drug-resistant TB (XDR-TB). In 2018,
at least one case of XDR-TB was reported by each of the 131
WHO Member States. However, over the past 15 years, the
average proportion of MDR-TB cases with XDR-TB reported
by 128 countries was 6.2% of all TB cases (World Health
Organization, 2019).
Macrophages are most common host cells of Mtb in
pulmonary TB. Therefore, the successful treatment of
pulmonary TB depends on the efficiency of TB drugs to
infiltrate complex lung lesions, penetrate the cell membrane of
macrophages and other host cells and finally, for the drugs to be
taken up by the intracellular Mtb (Dartois, 2014). A study by
Gurumurthy et al., demonstrated that TB drugs are malabsorbed,
rifampin in particular, was found to be malabsorbed in patients
with advanced HIV and diarrhea and cryptosporidial infection.
The bioavailability of INH was found to be more reduced in
rapid acetylators, while the absorption of EMB and PZA was also
reduced in the same patient group. These results suggest that theFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 2malabsorption of anti-TB drugs in TB patients with HIV, and
diarrhea could be one of the factors affecting the success of anti-
TB therapy in this patient cluster (Gurumurthy et al., 2004).
Anti-TB fixed dose combination (FDC) drugs and products
have been described as unstable in formulations due to chemical
interactions between the drugs, this incompatibility can also lead
to a reduction in the bioavailability of the drugs during oral
administration. Therefore, in a previous study by Aucamp et al.,
interactions as well as possible incompatibilities between the four
commonly prescribed commercial anti-TB FDC drugs were
investigated at a temperature of 50°C. The study revealed that
INH and RIF are chemically incompatible (Aucamp et al., 2019).
Anti-TB drugs should also be taken on an empty stomach to
reduce interaction with various foods, which results in the
absortion of these drugs being reduced. In addition, anti-TB
drugs also interact with other drugs when taken as part of a
combination treatment, this interaction with foods and/or other
drugs has been shown to increase the side effect inducing
capacity of anti-TB drugs e.g., interaction between isonizid
with levodopa, or carbohydrate rich foods (Arbex et al., 2010).
First-line and second-line TB drugs have been shown to posess
different intracellular uptake properties, and intracellular to
extracellular (I/E) ratios ranging between 0.1 to >20. In both in
vitro and in vivo studies, aminoglycosides and b-lactams
(antibiotics that are used to treat XDR TB) were found to have
I/E ratios that were below 1, the I/E ratio of INH was found to be
approximately 1. On the other hand, the I/E ratio ofRIF ranged
between two and five, while the I/E ratios of ETH and the
macrolides were shown to range between 10 to >20 (Johnson
et al., 1980; Hand et al., 1984). Fluoroquinolones have also been
found to have variable intracellular penetration properties: the
concentrations of moxifloxacin (MXF) have been shown to be
20–70 fold higher in pulmonary alveolar macrophages when
compared to the concentrations in the plasma (Soman et al.,
1999). The concentrations of levofloxacin were only marginally
higher in alveolar cells when compared with concentrations in the
plasma (Andrews et al., 1997). On the other hand, ciprofloxacin
was found to have an alveolar macrophage to plasma ratio of
5–10, indicating an intermediate penetration capacity (Schüler
et al., 1997).
The penetration and accumulation of TB drugs inside Mtb
is the final step of the long journey the drugs have to take
to reach the site of action. The reduced permeability of Mtb to
small-molecule drugs has also been shown to contribute to
the drug tolerance found in the dormant Mtb population
(Dartois, 2014). Nutrient-starved non-replicating Mtb also
display a significant reduction in intracellular accumulation of
fluoroquinolones, which may help explain the resistence of
quiescent Mtb against fluoroquinolone activity (Sarathy et al.,
2013a). Polyamines decrease the ability of drugs to permeate
Mtb, and have also been shown to prevent the uptake of
fluoroquinolones by the mycobacteria (Sarathy et al., 2013b).
These results, therefore suggest that the intracellular production
of polyamines by macrophages might be partially responsible for
the dormancy and phenotypic drug resistance of intracellular
Mtb (Dartois, 2014).February 2021 | Volume 10 | Article 618414
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approaches for the treatment of TB (Kimmey and Stallings, 2016;
Kaufmann et al., 2018; Paik et al., 2019). Host directed therapy
(HDT) is a novel and promising concept in TB treatment, where
small molecules, together with or without additional antibodies,
are used to modify host responsesto better control the
progression of TB. HDT drugs are distinct from antibiotics, as
they directly modulate the functions of host cells without
interacting with Mtb; thereby preventing the development of
drug resistance by the infecting pathogen (Kolloli and Subbian,
2017; Paik et al., 2019). The applications of HDT-TB can possibly
be effective in the treatment of MDR or XDR-TB through the
therapeutic targeting of various clinically relevant biological
pathways in hosts. Modulation of pathological or protective
responses in hosts has revealed that various components of the
immune system are central therapeutic targets for HDT against
TB (Zumla et al., 2016; Kolloli and Subbian, 2017; Paik
et al., 2019).
Autophagy is an intracellular catabolic process that assists in
the maintainance of homeostasis or the removal of invading
pathogens through a lysosomal degradation mechanism. The
activation of autophagy in infected host cells, through the use of
various drugs/compounds is a promising treatment strategy
against Mtb infection, which may also work against drug-
resistant strains with or without adjunctive agents (Gupta
et al., 2016; Kimmey and Stallings, 2016; Paik et al., 2019). As
autophagy and HDT are still relatively new approaches in TB,
there is a scarcity of research focusing on the delivery of
autophagy inducing compounds (AICs) and the treatment
duration of autophagy therapy aspecially when combined with
conventional antibiotic treatment. However, it is still necessary
to directly deliver the AICs to the infected cells/tissues/organs to
prevent unwanted side effects and delivery to non-target cells
(Paik et al., 2019).
Nanoparticles (NPs) can be utilized as a delivery system to
improve the activity of AICs against intracellular Mtb by
transporting the encapsulated AICs to their target sites while
protecting them from biodegradation and enhancing their
absorption across biological barriers (Dube et al., 2013;
Tukulula et al., 2018). NPs also allow for sustained drug
release in the target tissue. This allows for the reduction of
dosing frequency, thus lessening the drug-associated side effects
in the process (Grabowski et al., 2013). In addition, the materials
used to synthesize the NPs can possess autophagy inducing
activity or the surface of the NPs can be functionalized with an
AIC (Bekale et al., 2018).
In this review, we focus on the macrophage responses toMtb
infection, in particular, the mechanistic aspects of autophagy
and the evasion of autophagy by intracellular Mtb. Due to the
overlap between the onset of autophagy and apoptosis; we also
focus on the relationship between apoptosis and autophagy. We
will also review known AICs in the context of Mtb infection.
Finally, we discuss the applications of NPs in inducing
autophagy with the intention of sharing insights to encourage
further research and development of nanomedicine HDTs for
the treatment of TB.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3UPTAKE OF MTB AND FATE WITHIN
MACROPHAGES
TB can be spread when people with active pulmonary TB expel
Mtb into the air, for example, by coughing. Aerosols of the
pathogen can persist in the air for a prolonged period of time and
once inhaled, the bacilli travel through the upper respiratory
tract to reach the alveoli in the lungs, where they are taken-up
primarily by alveolar macrophages, type 2 pneumocytes and
polymorphonuclear neutrophils (PMNs). However, alveolar
macrophages commonly act as the first line of defense against
the pathogen (Silva Miranda et al., 2012; Dartois, 2014; Bekale
et al., 2018). Mtb is internalized by macrophages through
phagocytosis and subsequently located within phagosomes,
which undergoa series of fusion events to mature and attain
anti-microbial properties. The progression of phagosome
maturation is actively regulated and driven by the network of
Rab GTPases (Rab), which also play a role in the identity of the
endosomal organelle (e.g., Rab5, early endosomes; Rab7, late
endosome), sorting of protein and lipids through the recycling
pathway as well as regulating membrane-fusion events
(Gruenberg and van der Goot, 2006; Gutierrez, 2013; Prashar
et al., 2017).
Therefore, the process of phagosome maturation is
characterized by the recruitment of specific Rab GTPases,
which ultimately facilitate the fusion between the phagosome
and the lysosome to form the phagolysosome, a cytoplasmic
body that contains a set of hydrolytic enzymes necessary for the
clearance of pathogens. Rab20, Rab34 and the proneurotropin
receptor sortilin have also been described as important regulators
of phagosome maturation and are thus critical in the control and
eradication of intracellular Mtb (Kasmapour et al., 2012;
Vazquez et al., 2016; Schnettger et al., 2017). The completion
of phagosome maturation is accompanied by a reduction in
intraphagosomal pH from neutral to the more acidic pH 5, via a
vesicular proton-pump ATPase (HC-V-ATPase)-dependent
process (Russell et al., 2009). Phagosomal acidification creates
a suitable environment for the production of reactive oxygen
species (ROS) and for the optimal activity of lysosomal digestive
enzymes; hence, the process is essential for the clearance of
intracellular Mtb (Vieira et al., 2002; Sun-Wada et al., 2009).SURFACE RECOGNITION AND
MACROPHAGE RESPONSES TO
MTB INFECTION
The uptake of Mtb by phagocytic macrophages is facilitated by
the recognition of Pathogen Associated Molecular Patterns
(PAMP) present at the bacterial surface by various Pattern
Recognition Receptors (PRRs) on the surface of macrophages
such as Scavenger Receptors (SR), cytosolic DNA sensors,C-type
Lectin Receptors (CLR/CTL), Fc Receptors (FcR) and Toll-Like
Receptors (TLR), mannose receptors, surfactant protein A
receptors, CD14, immunoglobulin receptors, and complementFebruary 2021 | Volume 10 | Article 618414
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et al., 2017). Phagocytosis, innate immune responses and various
cellular processes such as antigen presentation, inflammasome
activation, autophagy, phagosome maturation, and apoptosis are
dependent on the stimulation of the PRRs (Queval et al., 2017).
Mtb has been shown to activate phagocytosis in macrophages by
interacting with TLRs. Recognition of Mtb is more specifically
facilitated by TLR2 using a variety of microbial structures, such as
the lipoproteins19 kDa, lipomannans (LM), lipoarabinomannan
(LAM) and the glycolipid phosphatidyl-myo-inositolmannoside
(PIM) (Quesniaux et al., 2004).
It has been noted that the loss of lipooligosaccharide (LOS)
production in the evolution of TB causing mycobacteria is
responsible for the rough colony morphology of these
pathogens, further contributing to enhancing the recognition
of Mtb by TLR2 (Boritsch et al., 2016). In addition, TLR9 has
been reported to recognize unmethylated CpGmotifs in bacterial
DNA (Bafica et al., 2005). These events trigger a signaling
cascade that stimulates Myeloid Differentiation primary
response protein 88 (MyD88) resulting in the activation of
pro-inflammatory cytokine production, activation and nuclear
translocation of transcription factors, including nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-kB) (Nigou
et al., 2001).
C-type lectin receptors (CLR/CTL) are a family of calcium
dependent membrane bound receptors that recognize
carbohydrate rich molecules. Among these receptors, the
mannose Receptor (MR) is one of the most well-known, and
recognizes mannose on the surface of Mtb. The stimulation of
macrophages through the MR has been shown to induce the
production of anti-inflammatory cytokines without activating
oxidative responses (Nigou et al., 2001). The Dendritic Cell
immune Activating Receptor (DCAR), Dectin-1, Dectin-2, C-
type lectin superfamily member 8 (Clecsf8) and the Mincle
receptor belong to a sub-family of the CLR and represent the
most known CLR expressed by macrophages (Yonekawa et al.,
2014; Marakalala and Ndlovu, 2017).
DCAR is an Fc receptor g-chain (FcRg) coupled receptor that
induces Th1 responses against Mtb infections by recognizing
PIM. T cells of DCAR-deficient mice have been shown to have
weakened IFN-g production resulting in elevated bacterial loads
(Marakalala and Ndlovu, 2017). Dectin-1 is a transmembrane
receptor with an extracellular C-type lectin-like domain (CRD)
and a cytoplasmic immunoreceptor tyrosine-based activation
motif (ITAM)-like domain (hemITAM). Dectin-1 is a known
fungal b (1, 3)-glucan receptor but the precise PAMP for Mtb
remains unknown. However, Dectin-1 triggers the production of
IL-12p40 in a Syk-dependent mannerin splenic DCs infected
with Mycobacterium Bovis (M. bovis) or pathogenic Mtb
(Dinadayala et al., 2004; van de Veerdonk et al., 2010;
Marakalala and Ndlovu, 2017).
Dectin-2 on the other hand, has been shown to recognize
ManLAM to induce host immune responses againstMtb infection.
The structure of Dectin-2 consists of a transmembrane domain, a
CRD, and a short cytoplasmic tail. The short tail recruits an
ITAM-linked FcRg, which activates signaling through Syk andFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 4possibly the Caspase recruitment domain family member 9/B-Cell
CLL/lymphoma 10/Mucosa-associated lymphoid tissue
lymphoma translocation protein 1 (CARD9/BCL10/MALT1)
complex. Dectin-2 has also been shown to recognize the virulent
Mtb H37Rv strain, however, the protective capacity of this
receptor against Mtb is yet to be demonstrated in vivo
(Toyonaga et al., 2016; Marakalala and Ndlovu, 2017).
The Mincle receptor recognizes and specifically binds to what
is thought to be likely the most abundant glycolipid in the
mycobacterial cell wall, the mycobacterial cord factor
Trehalose-6,6-dimycolate (TDM) (Ishikawa et al., 2009;
Marakalala and Ndlovu, 2017). The ligation of TDM to Mincle
triggers the generation of Th1/Th17 immune responses,
production of pro-inflammatory cytokines and granuloma
formation (Ishikawa et al., 2009; Marakalala and Ndlovu, 2017;
Mishra et al., 2017). Clecsf8 also interacts with mycobacteria
through the TDM glycolipid. This PRR is commonly expressed
on macrophages, classical monocytes, peripheral blood
neutrophils, and by a subsets of dendritic cells (DCs). Upon
engaging with TDM, Clecsf8 stimulates Mincle expression
through a protein to protein interaction, resulting in an
increase in intracellular responses. Downstream signaling of
this FcRg-coupled receptor is mediated through Syk kinase and
CARD9/BCL10/MALT1 pathways and induces various
intracellular responses, including NF-kb activation, pro-
inflammatory cytokine production, phagocytosis, and
respiratory burst. Clecsf8 interaction with TDM also induces
DC maturation and T-cell priming (Marakalala and
Ndlovu, 2017).
Complement Receptor (CR) and Fc receptors are also highly
expressed on the surface of macrophages and CR3 has been
shown to help facilitate the phagocytosis ofMtb by macrophages
through the recognition of PIM and/or Mtb polysaccharides
(Villeneuve et al., 2005). Mammalian monocytes and
macrophages express scavenger receptors to recognize oxidized
or acetylated lipoproteins. The Macrophage Receptor with
Collagenous (MARCO) structure is the most studied scavenger
receptor and has been found to cooperate with TLR2 to stimulate
the secretion of proinflammatory cytokines and the activation of
transcriptional factor NF-kB through the recognition of TDM
(Bowdish et al., 2009). DCs and macrophages use Dendritic Cell
Specific Intercellular adhesion molecule-3 Grabbing Non-
integrin (DCSIGN/CD209) to recognize conserved sugar
motifs on various parasites, viruses, and bacteria, including
Mtb (Tanne and Neyrolles, 2010).CELL DEATH IN MTB INFECTED
MACROPHAGES
The failure to eradicate intracellular Mtb post-infection, results
in either the active or latent form of TB. In the latent phase, an
assortment of immune cells (more macrophages, lymphocytes
and DCs) are recruited to the region of infection to keep the
intracellular bacteria inactive. Together these cells may at timesFebruary 2021 | Volume 10 | Article 618414
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a core composed ofMtb infected macrophages. In the presence of
activated T cells, the granuloma becomes fully organized and the
core becomes enclosed with lymphocytes (mainly g/d T Cells,
CD4+ and CD8+) which initiate the secretion of IL-8, IL-12,
TNF-a, and other pro-inflammatory cytokines by macrophages
(Ehlers and Schaible, 2012; Hajipour et al., 2012; Nasiruddin
et al., 2017). The end result consists of a continuous balance
between necrotic infected cells and the recruitement of new
phagocytes onto the granuloma is known as latency and is one of
the hallmarks of latent TB (van Crevel et al., 2002; Hajipour et al.,
2012; Nasiruddin et al., 2017).
However, this impasse between the host and pathogen, is
dynamic and consists of an equilibrium between cell death and
replenishment through cellular recruitment, as well as vascular
and tissue remodeling (Ehlers and Schaible, 2012). The bacteria
can persist within the granuloma in a latent state for prolonged
periods of time (lasting up to the lifetime of the individual),
however, as illustrated in Figure 1, a weakened immune systemFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 5(e.g., due to malnutrition, HIV infection etc.) can lead to the
reactivation of the Mtb. In this active phase, the bacteria can
begin to proliferate, ultimately inciting the death of the infected
macrophages through necrosis (Silva Miranda et al., 2012). Mtb
can now exit the granuloma and further disseminate to form
lesions in other regions of the lungs. The active Mtb can also be
transmitted to other individuals through for example, coughing
(Mueller and Pieters, 2006).
Macrophages infected withMtb commonly express two types
of cell death, i.e., necrosis: a death modality that ends in cell lysis
and apoptosis: a form of cell death that maintains an intact cell
membrane (Figure 2) (Behar et al., 2011). Apoptosis can be
instigated through various mechanisms; nonetheless, the process
is defined using several molecular and morphological decisive
factors. The common hallmarks of apoptosis are DNA
fragmantation, exposure of phosphatidylserine on the outer
leaflet of the plasma membrane, and lastly, containment of
cellular components in membrane-bound blebs (Behar
et al., 2011).FIGURE 1 | Transmission and pathogenesis of TB after Mtb infection. (A) Macrophages use PRRs to take up Mtb by recognizing various PAMPs on the
surface of the bacteria. Recognition of Mtb is more precisely facilitated by TLR2, which triggers phagocytosis, innate immune responses and various cellular
processes such as antigen presentation, inflammasome activation, autophagy, and apoptosis resulting in the eradication of intracellular Mtb. (B) However,
failure to eradicate intracellular Mtb after infection, results in either the latent or active form of TB. In the latent phase, the Mtb can remain dormant within the
granuloma for years. However, when the immune system becomes weakened, Mtb can become reactivated, subsequently inducing the death of the
infected macrophages through necrosis.February 2021 | Volume 10 | Article 618414
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THE MITOCHONDRIA IN THE INDUCTION
OF APOPTOSIS AND NECROSIS
Vertebrate cells generally undergo apoptosis by utilizing the
intrinsic apoptotic pathway; relying on mitochondrial outer
membrane permeabilization (MOMP) as the defining hallmark
(Green and Kroemer, 2004). MOMP facilitates the release of
apoptosis inducing factor, Smac-DIABLO, cytochrome c, and
other factors from the mitochondrial intermembrane resulting in
the activation of caspase-3/7 which are responsible for the
induction of apoptosis. These events can also occur due to the
opening of the mitochondrial inner membrane pore
(permeability transition pore), resulting in the loss of the
mitochondrial intermembrane potential (Dym), mitochondrial
permeability transition (MPT), and ultimately the induction of
necrosis. Mtb infections have also been shown to induce these
changes in mitochondrial membranes; therefore, these changes
are believed to determine the mode of death in infected
macrophages (Behar et al., 2011).
In the first scenario, MPT can cause the mitochondria to
become permeable to water, resulting in swelling, dysfunction,
and ultimately necrosis (Green and Kroemer, 2004). In the
second scenario, MOMP can occur as a by-product of the
outer mitochondrial membrane damage caused by irreversible
MPT. Such a scenario can materialize when hepatocytes undergoFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 6apoptosis and/or necrosis due to oxidative stress, or other toxic
treatments (Kim et al., 2003). However, the occurance of
apoptosis and MOMP is not always dependent on MPT. In
this scenario, members of the Bcl-2 family of apoptosis inducing
proteins, for example, induce MOMP without affecting the
mitochondrial inner membrane (Chipuk and Green, 2008).
More specifically, processed Bcl-2 only protein BID activates
the proapoptotic Bcl-2 family proteins BAX and BAK which
subsequently induce MOMP and translocation of proapoptotic
factorsinto the cytosol, resulting in the activation of caspase-9,
caspase-3 and ultimately apoptosis (Behar et al., 2011).
A permeable mitochondrial outer membrane allows for effector
molecules to damage the mitochondrial inner membrane by
gaining access into the mitochondrial intermembrane space.
This could be the same mechanism utilized by capase-3 to
damage a component of the electron transport chain called
Ndufs1 (Ricci et al., 2004). Ndufs1 damage induces ROS
production by disrupting the electron transport chain in the
inner membrane, resulting in necrosis. It is believed that
caspase-3 gains access to the mitochondrial intermembrane
space through a permeable mitochondrial outer membrane,
which also facilitates the escape of proapoptotic factors
including cytochrome c into the cytosol (Behar et al., 2011).
Finally, there is a scenario where MPT can occur independently
from the induction of MOMP. This is believed to be a mechanism
utilized by the protease, granzyme A, to damage the componentsFIGURE 2 | The induction of apoptosis and/or necroptosis by TNF in Mtb infected macrophages. TLR2 can be stimulated by different components of the Mtb
cell wall, which triggers the translocation of NF-kB to the nucleus resulting in the silmultaneous expression of TNF through a myeloid differentiation factor 88
(MyD88) dependent approach. The binding of TNF to TNFR1, induces the binding of TRADD to RIP1 and TRAF2/5, which consecutively bind to cIAP1/2 to
make up complex I. cIAPs facilitates the Lys-63-linked polyubiquitination of RIP1 or TRAF2 resulting in Lys 63-linked proteasomal degradation of IkB. The
resulting NF-kB translocates into the nucleus and triggers the transcription of various genes including A20 and CYLD. RIP1 becomes deubiquitinated by A20
and CYLD, futher switching complex I into complex II, which then initiates apoptosis through the recruitment and activation of Caspase-8. Casepase 8
inactivation triggers the formation of complex III, which induces the recruitment of RIP3 by RIP1 and subsequently the recruitment of MLKL by RIP3, ultimately
resulting in necroptosis. Adapted from (Xu et al., 2014).February 2021 | Volume 10 | Article 618414
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Granzyme A enters the mitochondrial intermembrane space
without damaging the mitochondrial outer membrane, due to
the cytosolic chaperone activity of Hsp70 and Hsp90. Once inside,
the protease cleaves Ndufs3 resulting in MPT (Martinvalet
et al., 2008).INDUCTION OF APOPTOSIS THROUGH
THE EXTRINSIC PATHWAY IN MTB
INFECTED MACROPHAGES
Various components of the mycobacterial cell wallcan stimulate
the production of tumor necrosis factor (TNF) in Mtb infected
macrophages through the TLR2-mediated signaling pathway.
TNF induces apoptosis through TNF receptors, which can be
found as either membrane-bound or in soluble form (Xu et al.,
2014). TNF minimizes the spread of Mtb by activating the
Caspase-8-mediated extrinsic cell death pathway (Behar et al.,
2011). Avirulent or attenuated Mtb strains such as Mtb H37Ra
have been shown to induce more macrophage apoptosis when
compared to virulent strains such as Mtb H37Rv, which have
been confirmed to elude TNF-dependent apoptosis by activating
the release of membrane-bound TNFR2 in solution, through an
IL-10 dependent pathway (Behar et al., 2011), and by increasing
the expression of Mcl-1 protein, a member of the anti-apoptotic
B-cell lymphoma/leukemia-2 (Bcl-2) family of proteins which
are located in the outer membrane of mitochondria (Xu
et al., 2014).
The virulent strain H37Rv has been shown to induce an
enhanced release of IL-10 in Mtb infected macrophages, when
compared to the attenuated strain H37Ra. This elevated IL-10
release triggers a greater build up of sTNFR2, which through the
formation of a soluble receptor-ligand complex leads to the
inhibition of TNF-a activity (Balcewicz-Sablinska et al., 1998).
Conversely, increased production of TNF has been shown to
induce mitochondrial ROS in infected macrophages via the
receptor interacting protein 1 (RIP1) receptor interacting
protein 3 (RIP3) mixed lineage kinase domain-like protein
(MLKL) dependent pathways. The mitochondrial ROS induces
a type of necrosis called necroptosis in Mtb infected
macrophages, which leads to the release of mycobacteria into
the extracellular environment (Wang et al., 2012). The repression
of RIP3 or MLKL has been shown to switch Mtb infected
macrophages from a state of TNF-induced necroptosis to a
state of delayed RIP1-dependent apoptosis (Han et al., 2011).
The stimulation of TNF receptor 1 (TNFR1) by TNF triggers the
binding of TRADD (TNF receptor-associated death domain) to
RIP1, TNF receptor-associated factor 2/5 (TRAF2/5) and cIAP1/
2 (cellular inhibitor of apoptosis 1/2) to form complex 1 (Xu
et al., 2014).
The Lys 63-linked polyubiquitination of RIP1 or TRAF2 by
cIAPs induces the translocation of NF-kB into the nucleus to
induce the transcription of A20 and cylindromatosis (CYLD),
which can both deubiquitinate RIP1 (Vandenabeele et al., 2010).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7Inhibition of cIAP proteins or deubiquitination of RIP1
facilitates the conversion of complex I to complex II, which is
comprised of FADD, RIP1, TRADD and Caspase-8 (Han et al.,
2011). Complex II facilitates the activation of Caspase-8 which
further instigates apoptosis. The inhibition of Caspase-8
activity triggers the recruitment of RIP3 by RIP1 to form
complex III (also called necrosome), which also comprises of
Caspase-8, FADD and possibly TRADD. RIP1 subsequently
phosphorylates RIP3 to recruits MLKL, resulting in the onset
of necroptosis. In addition, the presence of inhibitors of
ubiquitinating enzymes, virulent strains of Mtb, and
deubquitinating enzymes keep Caspase-8 inactive (Xu
et al., 2014).
Therefore, avirulent Mtb strains tend to stimulate apoptosis,
whereas virulentMtb strains are inclined to trigger necroptosis, a
type of cell death known to favourthe pathogen and facilitate the
dissemination of Mtb (Jayaraman et al., 2013). These
observations suggest that at some point during the infection,
virulent Mtb strains stimulate higher expression of TNF when
compared to avirulent strains resulting in necroptosis. In
addition, virulent strains possibly secrete a biological agent that
blocks the activity of Caspase-8, reslting in the inhibition of
apoptosis. In contrast, avirulent strains might be lack this ability
(Xu et al., 2014).
Macrophage apoptosis is associated with an increase in ROS
production. During apoptosis, DCs engulf and facilitate the
degradation of the Mtb or Mtb product containing apoptotic
bodies by cross-presenting the bacterial antigens to CD8+ T cells
through a process called efferocytosis (Lee et al., 2004; Ashida
et al., 2011; Silva Miranda et al., 2012). The binding of apoptotic
bodies to the phagocytes during efferocytosis triggers the
expression of anti-inflammatory cytokines such as interleukin-
10 (IL-10) and transforming growth factor-b. The suppression of
inflammation by these cytokines is believed to assist in
minimizing the tissue damage caused by the accidental release
of intracellular contents, including degradative enzymes, to the
extracellular space (Lee et al., 2009). As the bacteria are typically
killed during this process, Mtb infected macrophages have
‘alternative activation’ which is characterized by the arrest of
phagosome maturation, increased secretion of macrophage
attractant chemokines and M2 cytokines, suppression of
microautophagy and apoptosis inhibition (Lancellotti et al.,
2006; Ashida et al., 2011).
Highly virulent Mtb strains are known to primarily induce
necrosis; however, apoptosis has also been detected in
macrophages infected with virulent Mtb (Figure 2). The
induction of apoptosis in Mtb infected macrophages has been
shown to be TNF-a dependent, although, the virulent Mtb
strains induce extensively less apoptosis in host cells when
compared to related attenuated strains (van Crevel et al., 2002;
Behar et al., 2011). This difference in apoptosis induction has
been explained using selective induction and release of
neutralizing soluble TNF-a receptors by pathogenic strains. In
turn, the release of TNF-a receptors is regulated by IL-10
production. Therefore, virulent strains of Mtb may selectively
induce the production of IL-10, resulting inreduced TNF-aFebruary 2021 | Volume 10 | Article 618414
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et al., 2002). However, it is still not clear whether virulent Mtb
inhibits the induction of apoptosis or prevents its completion by
locking its downstream events (Behar et al., 2011).
The TLR2 dependent activation of the NF-kB cell survival
pathway and the enhanced production of the soluble TNF
receptor 2 (sTNFR2), neutralize the activity of TNFR1
resulting in Mtb persisting inside the macrophage phagosomes
in either an active form or a dormant form (Lancellotti et al.,
2006; Ashida et al., 2011). Therefore, in order to investigate the
role of apoptotic macrophages in adaptive immunity, a new
adoptive transfer model has been developed where in vitro Mtb
infected macrophages have been transferred from wild type or
knockout mice and instilled into normal recipient mice via the
trachea. This approach has been used to study the influence of
macrophage genotypes on the T-cell response and control of
infection (Divangahi et al., 2010).ROLE OF EICOSANOIDS IN
MITOCHONDRIAL PROTECTION
Recent studies have investigatedhow the eicosanoid
prostaglandin (PGE2) and lipoxins (LXs) regulate programmed
celldeath in Mtb infected macrophages (Figure 3) .
Cyclooxygenases (COX), namely COX1 and COX2, are
responsible for the production of PGs by metabolizing
arachidonic acid into PGH (Kurtz et al., 2006; Behar et al.,
2011). The various PGs produced comprise of PGD2, PGE2,
PGF2a, PGI2, and thromboxane. Among these, PGE2 is the most
studied PG, and has a variety of biological functions triggered byFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 8interacting withany of its four specific receptors EP1, EP2, EP3,
and EP4 (Kurtz et al., 2006; Behar et al., 2011). The interaction
between PGE2 and the EP2 receptor prevents bacteria induced
damage to the mitochondria in macrophages. On the contrary,
interacting with EP4 triggers the repair of the plasma membrane
in infected macrophages through the recruitment of lysosomal
membranes to the cell surface (Behar et al., 2011).
Mtb H37Ra has been shown to stimulate PGE2 in host
macrophages; however, virulent Mtb has been demonstrated to
stimulate the production of LXA4in macrophages (Bousso,
2008). In these cells, 5-lipoxygenase (5-LO) metabolizes
arachidonic acid to produce LXA4. The ensuing LXA4 plays a
key role in the onset of inflammation and has been shown to
stimulate macrophages to engulf apoptotic neutrophils using
phagocytosis (Behar et al., 2011). LXA4 inhibitsthe expression of
COX2 and thus, the generation of PGE2, subsequently
redirecting the fate of the infected macrophage to necrosis.
Other pro-necrotic roles of LXA4 include inhibiting the
stimulation ofapoptosis by lipopolysaccharide/interferon-g,
prevention of the secretion of pro-apoptotic mediators by the
mitochondria, as well as inhibiting caspase activation and ROS
generation. This data establishes LXA4 as the most important
mediator of necrosis (Behar et al., 2011).
The fate of the macrophage following Mtb infection is a key
component of the immune response against the pathogen.
Several PGE2 dependant cellular pathways have been found to
promote apoptosis while preventing necrosis in Mtb infected
macrophages (Bousso, 2008). These pathways include the
induction of prostaglandin H (PGH) synthase which is
propelled by membrane associated prostaglandin E synthase-1
(mPGES) to produce PGE2, the production of COX2,
transcription of synaptotagmin-7 (Syt-7), a lysosomal Ca 2+FIGURE 3 | The roles played by eicosanoids and lipoxins in regulating the death of infected macrophages. The balance between prostanoid and lipoxin production
is the dictator of the modality of death in Mtb infected macrophages. Increased production of LXA4 induces necrosis; whereas, excess production of PGE2 inhibits
necrosis and favors apoptosis. Adapted from (Behar et al., 2011).February 2021 | Volume 10 | Article 618414
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lysosomal vesicles requiredto induce apoptosis, prevention of
irreversible damage of the mitochondrial inner membrane by
virulent Mtb strains using MPT (Bousso, 2008), and the
production of plasminogen activator inhibitor type 2 (serpin
B2) (Winau et al., 2006).
In addition, PGE2 also induces the transcription of Syt-7,
which facilitates the repair of the plasma membrane repair by
means of lysosomal exocytosis (Pozzi et al., 2005). There are
numerous PGE2 dependent mechanisms leading to apoptosis,
and the balance between the production of PGE2 and LXA4
regulates the number of cells undergoing apoptosis or necrosis
(Behar et al., 2011).AUTOPHAGY AS AN INNATE IMMUNE
DEFENSE MECHANISM
Autophagy is a homeostatic lysosomal process that involves the
degradation of cellular components to their basic elements as a
response to stress conditions (Lam et al., 2017; Paik et al., 2019).
Based on how the cargo is targeted and delivered to the lysosomes,
the autophagy pathway can be catagorized into three different types
of autophagy processes, i.e., macroautophagy, microautophagy, and
chaperone-mediated autophagy. Macroautophagy (generally
referred to as autophagy) is triggered by numerous stress signals
such as damaged intracellular organelles, hypoxia, starvation, and
microbial infection (Lam et al., 2017; Paik et al., 2019). As illustrated
in Figure 4, autophagy is initiated by the formation of the early
phagophores (isolation membrane) from the endoplasmic
reticulum–mitochondria contact sites, followed by the expansionFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 9of the phagophores around the intra-cytoplasmic cargo, and the
growth of the phagophores into double membrane
autophagosomes. Eventually, the autophagosomes become
autolysosomes by coalescing with endosomes/lysosomes to
facilitate the degradation of cytoplasmic cargo. Autophagy is also
essentialfor the regulation of various immune responses, including:
inflammation, innate immunity, and macrophage antibacterial
defenses (Lam et al., 2017; Paik et al., 2019).
Bacteria mainly use pathogen induced damage-associated
molecular patterns (DAMPs) and PAMPs to induce autophagy
in host cells (Deretic et al., 2015; Shibutani et al., 2015). Cell
surface recognition and cytosolic sensing of these molecules
triggers signaling cascades that stimulatethe rapid and localized
recruitment of the autophagy machinery (van der Vaart et al.,
2014). Transcriptional factors such as NF-kB and transcription
factor EB (TFEB) can further regulate autophagy by promoting
the expression of diverse autophagy genes that extend the
activation of autophagy (van der Vaart et al., 2014; Pastore
et al., 2016).
The IL-12 and IL-18 dependent secretion of interferon
gamma (IFN-g), together with the production of tumor
necrosis factor alpha (TNF-a) have all been shown to be vital
in the defensive instigation of autophagy against Mtb infection
(Salgame, 2005). IFN-g induces autophagy in both human and
murine macrophage cell lines; this type of autophagy reduces the
survival of intracellular virulentMtb H37Rv. IFN-g enhances the
translocation of LC3 and the proteolysis of long-lived proteins,
which are both autophagy markers, and subsequently increases
autophagosome formation (Shi and Kehrl, 2010). Upon IFN-g
stimulation, GTPase (IRGM1), an autophagy linked gene
downstream of IFN-g, controls Mtb replication throughFIGURE 4 | Overview of macroautophagy. Macroautophagy is one of autophagic process which is induced by various stimuli or stress including infection.
Autophagy sequesters aggregated proteins, damaged organelles, and microbes from cytoplasm through formation of double-membraned structure
(autophagosome). These autophagosomes fuse with lysosome or endosome that contains endocytic compartments to form amphisome or autolysosome. Finally,
cargos are degraded in autolysosome for the maintenance of cellular homeostasis. Adapted from (Songane et al., 2012).February 2021 | Volume 10 | Article 618414
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of Mtb containing phagosomes, and autophagolysosome
formation through the fusion of the phagosome to the lysosome
(MacMicking et al., 2003).
The delivery of H+-ATP and lysosomal hydrolases from the
trans-Golgi network to the phagosome as well as the fusion of the
phagosome with the lysosome enhances the acidification of the
internal environment of the autophagolysosome or
autolysosome resulting in the killing of Mtb (Fratti et al., 2003;
Songane et al., 2012). Treatment of Mtb infected macrophages
with TNF-a leads to an increase inIFN-g induced phagosome
maturation in these macrophages (Songane et al., 2012).
Autophagy can also produce and supply antimicrobial peptides
to the bacterial compartment to improve the bacterial killing
(Alonso et al., 2007). Depending on the nature and localization of
PAMP/DAMP, autophagy can use a mechanism called
xenophagy to selectively capture and eradicate bacteria,
damaged organelles, and other signaling platforms activated
during the infection process (Bah and Vergne, 2017).XENOPHAGY
Xenophagy refers to the process whereby cells use autophagy
against pathogens and this cellular mechanism has been found to
be an innate component of immune responses. Xenophagy is
triggered against Mtb infection by the cytoplasmic release of the
bacteria through the Mtb ESX-1 secretion system (Watson et al.,
2012; Paik et al., 2019). The autophagic receptors p62 and
NDP52, and the STING dependent cytosolic pathway play a
crucial role in the elimination of Mtb by xenophagy (WatsonFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 10et al., 2012; Franco et al., 2017). Mice possessing monocyte
derived cells and neutrophils that are devoid of Atg5 have been
shown to be more susceptible to Mtb infection. However, other
Atgs such as Beclin-1 and Atg14 (Figure 5), were found to cause
no susceptibility. These results therefore suggest that autophagy
may not be involved in regulating the initial stages of infection,
however these claims are yet to be confirmed (Castillo et al.,
2012; Watson et al., 2012; Kimmey et al., 2015).
Mtb can also damage the phagosomal membrane and access
the cytosol using its ESX-1 secretion system (Watson et al., 2012).
Cytosolic sensor c-GAS can recognizethe bacteria’s DNA, thus
inducing ubiquitination of the bacteria or its phagosome capture
using ubiquitin ligases Parkin and Smurf1 (Watson et al., 2015;
Franco et al., 2017). As a result, ubiquitin chains bind to autophagy
adaptors, such as p62 and NDP52, recruitmicrotubule-associated-
protein-1 light chain 3 (LC3) which subsequently delivers Mtb
into an autophagosome. Cytosolic lectins of the galectin family
also recognize the host glycan present on the lumen of damaged
phagosomes, subsequently targeting these damage phagosomes for
degradation by means of the autophagosome (Gomes and Dikic,
2014; Chauhan et al., 2015b).LC3-ASSOCIATED PHAGOCYTOSIS
LC3-associated phagocytosis (LAP) is a non-canonical autophagy
process known to play a significant role in antibacterial defenses in
macrophages (Galluzzi et al., 2017; Mitchell and Isberg, 2017).
During LAP, pathogens are taken up by macrophages through
phagocytosis. Binding of pathogens on surface receptors, such as
the Fc gamma receptors, toll-like receptors, or Dectin-1, triggersFIGURE 5 | The roles of autophagy in macrophage defences against bacterial infections. (A) Cytosolic and vascular pathogens are selectively captured and
degraded in the lysosome through a process called xenophagy. Xenophagy depends on ULK1, autophagy related (Atg) 14, Atg5-12, Beclin-1, autophagy receptor
proteins, such as p62 and requires formation of an autophagosome. Autophagosomes capture bacterial compartments either through ubiquitination or through host
glycan recognition by galectins. (B) Autophagy regulates inflammation by restraining inflammasome activation. This can be archieved by inhibiting the production of
inflammasome subunits or through the elimination of damaged mitochondria, using a process called mitophagy. Adapted from (Bah and Vergne, 2017).February 2021 | Volume 10 | Article 618414
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requiring autophagosome formation (Sanjuan et al., 2007; Huang
et al., 2009; Ma et al., 2012). Unlike canonical autophagy, LAP
depends on the activation of Beclin-1/Rubicon complex and
NADPH oxidase-2 (NOX2) and does not rely on ULK1 or
Beclin-1/Atg14 complexes (Huang et al., 2009; Martinez et al.,
2015). LC3 conjugation is triggered by the recruitment of two
ubiquitin-like conjugation systems that are promoted by
phosphatidylinositol-3-phosphate (PI3P) and ROS. The
production of ROS has been shown to be PI3P dependent,
whereas the synthesis of PI3P relies on Rubicon. The MORN2
protein has also been implicated in the LC3 conjugation pathway,
though its role in the process remains unknown (Abnave
et al., 2014).
A number of studies have shown that the conjugation of LC3
onto the phagosome improves the fusion between the
phagosome and the lysosome. As a result, macrophages with a
deficient LAP pathway are less effective at controlling
intracellular growth of numerous bacteria including Mtb,
Staphylococcus aureus, Legionella pneumophila, M. bovis BCG,
and Listeria monocytogenes (Yang et al., 2012; Abnave et al.,
2014). In addition, Rubicon-deficient mice have been shown to
retain a larger bacterial load and are more vulnerable to L.
Monocytogenes infection (Yang et al., 2012). LAP has also been
shown to assist in antigen presentation process viaMHC class II
molecules, thus bridging the gap between innate and adaptive
immunity (Ma et al., 2012; Romao et al., 2013).
However, it is important to note that LC3 conjugation at
times delays or does not affect phagosome maturation. This
indicates that LC3 alone is not enough to drive the fusion of theFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 11phagosome with the lysosome (Bah and Vergne, 2017).
Autophagy can also indirectly regulate phagocytosis by varying
the expression of phagocytic surface receptors. For example,
suppression of the Atg 7 protein synthesis in macrophages
promotes the upregulation of MARCO and MSR1, two class-A
scavenger receptors that enable phagocytosis of M. bovis BCG
and Mtb (Bonilla et al., 2013). Autophagy-deficient cells have
also been shown to amass p62, thus promoting the dissociation
of transcription factor nuclear erythroid-related factor 2
(NFE2L2) from Keap1 and its subsequent translocation into
the nucleus, where it facilitates the expression of these receptors.
In some cases, the lack of autophagy during infection can lead to
reduced phagocytosis dependent on the bacteria (Jacquel
et al., 2012).REACTIVE OXYGEN SPECIES-MEDIATED
AUTOPHAGY AGAINST MTB INFECTIONS
ROS serve as signaling molecules that are involved in various
cellular processes and play a key role in the killing of intracellular
pathogens in macrophages (Lammas et al., 1997). Phagocytosis is
a first-line innate immune defense mechanism. As illustrated on
Figure 6, this process can be activated through the stimulation of
specific membrane receptors, such as the b-glucan receptor,
complement receptors, Fcg receptors (FcgRs) or TLRs. Previous
studies have revealed that the activation of TLR signaling during
phagocytosis induces the recruitment of the LC3 autophagy
protein to the phagosome, hence promoting phagosomeFIGURE 6 | ROS production as an immune response against Mtb infections. Stimulation of either FcgRs or TLRs during phagocytosis activates similar kinetics to
induce theactivation of ROS dependent autophagy. These two receptors activate the NOX2 NADPH oxidase, which is responsible for the production of ROS.
Rubicon has also been shown to be an important positive regulator of the NADPH oxidase complex. During Mtb infection, the bacteria stimulate TLR2 resulting in
the activation of Rubicon to interact with the p22phox subunit of the NADPH oxidase complex, enabling its phagosomal trafficking to induce the production of NOX2
dependent ROS, which leads to the recruitment of LC3 to the phagosome and ultimately the onset of autophagy and phagosome maturation through the assistance
of Bectin-1.February 2021 | Volume 10 | Article 618414
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tethering, which results in microbial killing (Huang et al.,
2009; Yang et al., 2012). FcgR and TLR signaling have been
shown to induce the assembly of NOX2 NADPH oxidase on the
nascent phagosomal membrane, which results in the production
of superoxide through the transfer of electrons from the cytosolic
NADPH to the oxygen in the phagosome lumen. Superoxide and
other ROS generated during this process are highly potent and
can directly kill intracellular microbes. The presence of NOX2-
generated ROS has also been revealed to be compulsory for
targeting LC3 to phagosomes (Huang et al., 2009; Yang
et al., 2012).
Upon TLR stimulation or microbial infection (using Listeria
monocytogenes), Rubicon was found to function as part of a
Beclin-1 containing autophagy complex and has been shown to
interact with the NADPH oxidase phagocytic complex, resulting
in, firstly, the activation of NADPH oxidase which induces ROS-
mediated antimicrobial oxidative activity; and secondly, the
activation of Beclin-1-kinase complex relocate to phagosomes
and trigger phagosomal maturation as a non-oxidative
antimicrobial activity (Yang et al., 2012). IFN-g inducible nitric
oxide synthase (iNOS) pathways are an important antimicrobial
alternative to the NADPH phagocyte oxidase pathways in
phagocytic cells, which facilitates the production of nitric oxide
(NO) radicals. Stimulation with zymosan, L. monocytogenes and
a combination of the two, was found to produce significantly
higher levels of ROS and NO in Raw264.7 Rubicon expressing
macrophages. However, Rubicon expression as a result of IFN-g
stimulation was found to only induce minor differences in ROS
and NO production. These results thus, suggest that Rubicon is
primarily involved in the TRL2 dependent antimicrobial activity
pathway, and that autophagy can either be ROS and NO
dependent or non-dependent (Yang et al., 2012).INFLAMMATION DAMPENING AGAINST
BACTERIAL INFECTIONS
Inflammation is crucial to control bacterial infections; however,
extreme inflammatory responses (cytokine storm) can result in
injured host tissue, thus facilitating the progression of the
disease. A number of studies have demonstrated that
autophagy regulates inflammation in both infectious and non-
infectious conditions (Shibutani et al., 2015; Cadwell, 2016). In
cases of infections, autophagy uses multiple mechanisms to
down-regulate the activation of inflammasomes (Saitoh and
Akira, 2016; Harris et al., 2017). Pseudomonas aeruginosa
infections damage the mitochondria, resulting in NLRC4
inflammasome. Autophagy el iminates the damaged
mitochondria througha process called mitophagy, thus limiting
inflammasome activation in both an in vitro and in vivo setting
(Jabir et al., 2015). Atg7 deficient mice have been shown to have
enhanced susceptibility to P. Aeruginosa infection resulting in
increased neutrophil infiltration and severe lung damage. Atg7
deficiency in alveolar macrophages promotes up-regulation of
IL-1b and pyroptosis (Pu et al., 2017). Aside frommitophagy,Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 12autophagy can also inhibit inflammasome activation by arresting
the production of inflammasome subunits (Shi et al., 2012;
Kimura et al., 2015).
It has also been shown that the mechanisms of autophagy are
greatly manipulated by the micro-environment of the macrophage.
Pro-inflammatory cytokines such as IFN-g, IL-1b, and TNF-a are
known to activate autophagy, whereas anti-inflammatory cytokines
IL-4, IL-10, and IL-13 seem to inhibit autophagy (Harris, 2011). The
recruitment of autophagy proteins p62 and Atg4B also promoted by
the IFN-g mediated xenophagy can only be accomplished through
the help of ubiquilin-1 and guanylate binding proteins 1 and 7 (Kim
et al., 2011; Sakowski et al., 2015). The presence of vitaminD in
serum has been demonstrated to significantly enhance autophagy in
macrophages by promoting the expression of cathelicidin, an
antimicrobial peptide (Yuk et al., 2009). T cells have also been
shownto induce autophagy in Mtb infected human macrophages
(Petruccioli et al., 2012). In addition, the probiotic, Bacillus
amyloliquefaciens, has also been shown to up-regulate autophagy
genes in macrophages, resulting in enhanced Escherichia coli (E.
coli) killing (Wu et al., 2017).EVASION OF AUTOPHAGY BY
INTRACELLULAR MTB
Regulation of Signaling Pathways Involved
in Autophagy Initiation
IntracellularMtb have developed a variety of strategies to overcome
the antibacterial defense of the macrophage, including autophagy
(Bah and Vergne, 2017). A majority of the uncovered strategies
presented in Figure 7, are mainly directed at and specifically target
distinct steps of xenophagy. Mtb have been shown to target the
JNK-dependent autophagy by secreting an N-acetyltransferase, Eis.
However, this type of autophagy does not show sufficient influence
on the intracellular growth of the pathogen (Shin et al., 2010; Kim
et al., 2012). In addition, both in vitro and in vivo studies have
demonstrated that Mtb inhibit the recruitment of NADPH oxidase
onto phagosomes that contain the pathogen, thus favoring
intracellular growth of Mtb (Koster et al., 2017).
Regulation of miRNA (miR) Targeting
Autophagy Machinery
Autophagy is commonly modulated via post-translational
modification. However, the process can also be modulated at a
post-transcriptional level through the expression of numerous small
non-coding RNAs (miR). Mtb impedes autophagy by down
regulating the expression of several autophagy proteins such as
Atg5, Atg12, LC3, and LAMP1 by means of inducing miR-33
expression (Ouimet et al., 2016). However, mice with hematopoietic
miR-33 deficiency have been demonstrated to retain their ability to
control Mtb infection. Mtb also targets UVRAG through the
expression of miR-125a in complex with Beclin-1 resulting in the
inhibition of autophagy in macrophages, therefore allowing for
the intracellular survival of Mtb in the process (Kim et al., 2017).
However, other studies have demonstrated that miR-33 and
miR-125a can be induced using PRR ligands separate from MtbFebruary 2021 | Volume 10 | Article 618414
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these miRs may be expressed as a normal negative feedback loop in
host cells to avoid excessive autophagy, which Mtb takes advantage
of. In addition,Mtb stimulates the up-regulation of miR-144* which
it uses to decrease the expression of DRAM2, a newly discovered
autophagy protein, responsible for promoting autophagosome
maturation by activating a second Beclin-1 complex (Kim et al.,
2017). Lastly, Mtb also promotes the expression of Mc1, which
targets and inhibits Bectin-1 complex, by down-regulating the
expression of miR-17, thus inhibiting autophagy (Kumar
et al., 2016).
Suppression of the Maturation
of Phagolysosomes
The Mtb secretes bacterial proteins ATP1/2 (secretion ATPase1/2,
secreted secA1/2 protein) and early secretory antigen-6/culture
filtrate protein to inhibit the accumulation of vacuolar ATP and
GTP enzymes, therefore decreasing intracellular pH, which results
in the suppression of phagocyte maturation (Rohde et al., 2007; Zhai
et al., 2019). Mtb also supresses the formation of lysosomes by
inducing an increase in the expression of the coronin 1 protein on
the host phagocyte membrane; the extent of the recruitment process
and the amount of coronin 1 are proportional to the amount of
activated Mtb in the microsomes (Schuller et al., 2001; Flynn and
Chan, 2003; Zhai et al., 2019).
The IFN cytokine interferon has also been shown to suppress
phagocyte maturation through the induction of IL-10 production inFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 13a STAT1-dependentmanner. IL-10 inhibits the caspase1-dependent
IL-1 maturation of pleural fluid mononuclear cells by reducing
excess IL-1 (Ma et al., 2014). Serine/threonine-protein kinase G
(PKnG) has been shown to augment the virulence, metabolism,
growth rate, and drug resistance ofMtb by increasing the infectivity
of Mtb lowering the expression of GlpK and ALD, increasing the
expression of Ag85A and Ag85C, and supressing the maturation of
lysosomes. PKnG also hinder the fusion of phagosomes and
lysosomes by increasing signal transduction in host cells
(Walburger et al., 2004; Wong et al., 2013).
Obstruction of Autophagosome–Lysosome
Fusion
As described earlier, Mtb can inhibit autophagosome maturation
using miR-144*, although, the bacterial factors involved in that
process are still unidentified (Kumar et al., 2016). A number of
studies have demonstrated that a vitalMtb virulence factor called
Esat-6 is involved in the process of inhibiting autophagosome
maturation in both macrophages and dendritic cells (Romagnoli
et al., 2012; Chandra et al., 2015). The exact role of Esat-6 in the
process is still unknown but it is estimated that it might be
partially facilitated by miR modulation (Kumar et al., 2015). A
number of other bacterial pathogens such as Chlamydia
trachomatis, Yersinia pestis, and Y. Pseudotuberculosis can also
block autophagosome maturation to insure their intracellular
survival or growth in macrophages, and similar to Mtb their
molecular mechanisms involved in the process remain unknownFIGURE 7 | The evasion of autophagy by intracellular Mtb. Intracellular Mtb have been shown to employ various strategies to evade autophagy in macrophages.
Among these, Mtb have been shown to induce the production of Eis, which results in the inhibition of ROS and ultimately autophagy. Mtb also impedes autophagy
by inducing miR-33 expression which in turn supresses the expression of numerous autophagy proteins including; Atg5, Atg12, LC3, and LAMP1. Mtb also induces
the expression of miR-125a which forms a complex with Beclin-1 resulting in the inhibition of UVRAG and ultimately the inhibition of autophagy in macrophages. Mtb
also stimulates the production ofmiR-144*, which inhibits DRAM2 resulting in the inhibition of autophagosome maturation. Lastly, intracellular Mtb also induces the
secretion of coronin1 by theinfected macrophages, which inhibits the fusion of phagosomes with lysosomes. All these autophagy evasion tactics therefore allow for
the intracellular survival of Mtb in the infected phagocytes.February 2021 | Volume 10 | Article 618414
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Mannosylated beads hinder phagosome maturation post
phagocytosis, indicating the plausible influence of glycolipids
on the survival of intracellular mycobacterium (Astarie-
Dequeker et al., 1999; Kang et al., 2005).
The pro-inflammatory transcription factor NF-kB has been
shown to control the release of lysosomal enzymes into
phagosomes, therefore regulating the killing of intracellular
pathogens. In addition, the fusion of phagolysosomes during
infection is also regulated by NF-kB, by increasing the
production of membrane transport molecules (Gutierrez et al.,
2008). The fusion between phagosomes and lysosomes is also
suppressed through the calmodulin dependent production of
phosphatidylinositol-3-phosphate (PI3P), lower biosynthesis
and via trafficking the toxin lipoarabinomannan (LAM) after
Mtb infection (Vergne et al., 2003). As mentioned above, Mtb
can survive and persist in macrophages by obstracting the fusion
between the lysosome and phagosome (Figure 7). In DCs, DC-
specific intercellular adhesion molecule-3 grabbing nonintegrin
(DC-SIGN) facilitates the entry of Mtb by interacting with the
mycobacterial cell wall component ManLAM. The interaction
between DC-SIGN and ManLAM leads to the supression of DC
maturation (Geijtenbeek et al., 2003; Tailleux et al., 2003).SUPRESSION OF THE ACIDIFICATION
OF PHAGOLYSOSOMES
Mtb inhibits phagosome acidification and persists by maintaining
a relatively lower acidic intracellular environment (pH~6.2).
Mtb initiates this process by changing the composition of the
phagosome; as the structure and particular molecules on the cell
wall function as a barrier that allows macrophages to retain a
neutral pH (Chen et al., 2015). This step is followed by encoding
the protein tyrosine kinase A (PtkA) in the same operon as PtpA.
IFN-g inducible nitric oxide synthase 2 has been shown to
directly activate Mtb infected macrophages, resulting in the
suppression of the replication of intracellular Mtb. LRG-47, a
member of the 47-kD guanosine triphosphate familyhas also
been demonstrated to play a protective nitric oxide synthase 2
independent role in macrophages against disease. As a result,
LRG-47 defient macrophages have a reduced response to Mtb
due to an inability to completely acidify (MacMicking
et al., 2003).INHIBITION OF THE FUNCTION OF
OXIDATIVE SPECIES
Oxidative stress refers to a state of imbalance between the pro
and antioxidants. Together with the inhibition of macrophage
phagocytosis, lysosome maturation and acidification, inhibition
of oxidative stress is mandatory process toward archieving Mtb
latency in the host cells. Oxidative stress can induce lipid
peroxidation, protein oxidation, and cause damage to DNA
bases. The mitochondria and the NADPH oxidase (NOX) are
the two main producers of ROS required to induce autophagyFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 14(Shin et al., 2010). NOX plays a key role in the elimination of
pathogens and the NOX deficiency in mice has been shown to
impair the mice’s ability to eradicate a number of pathogens
(Fang, 2004).
However, Mtb has been shown to have the ability to
deactivate NOX2-derived ROS (Miller et al., 2010), although it
is still unclear if there is increased susceptibility to TB in patients
with chronic granulomatous disease (CGD) that causes ROS
defects as a result of genetic defects in NADPH oxidase. This is
because patients with CGD are almost only identified and
diagnosed in developed countries where there is a very low
prevalence of TB, therefore it is unknown if these patients have
increased susceptibility or show a flawed autophagy process
against Mtb in countries with a high prevalence of TB
(Songane et al., 2012). The presence of SigH, an Mtb
alternative sigma factore induced by heat, oxidative and nitric
oxide stresses, has been shown to becompulsory for long lasting
Mtb infection. The interaction of host innate immune responses
with Mtb is also regulated by a SigH-dependent regulon (Dutta
et al., 2012).
Mycothiol (MSH), a major thiol in Mtb, has been shown to
have antioxidant activity and helps Mtb persist in macrophages
through the detoxification of various intracellular compounds.
The gene mshD encodes for mycothiol synthase, the final
enzyme in the biosynthesis of MSH. A strain of Mtb devoid of
an mshD gene has been shown to be sensitive to H2O2 and also
displays poor growth on catalase and oleic acid deficient agar
plates (Buchmeier et al., 2006). Polymorphonuclear neutrophils
(PMNs) eliminate pathogens and are key components in the first
line of defense against Mtb through the induction of ROS
production (Schuller et al., 2001). The enzymes KatG and
TrxB2 have been shown to help Mtb with stand the oxidative
environment and the expression of their related genes are
notably increased by H2O2 and NO (Lamichhane, 2011).
In addition, Mtb also produces the protein Eis to enhance its
intracellular survival through the blockade of ROS production,
thus inhibiting macrophage inflammatory responses, cell death
and autophagy (Shin et al., 2010). The Eis protein has been
located in the cytoplasm and in Mtb containing phagosomes of
infected macrophages (Samuel et al., 2007). In addition, traces of
anti-Eis antibodies have also been detected in sera obtained from
patients with pulmonary TB, thus signifying that Eis is produced
during Mtb infection in humans (Dahl et al., 2001). Finally, Eis
deficient Mtb infections have been shown to induce increased
caspase-dependent cell death in the host cells, however, this cell
death can be inhibited by blocking autophagy and c-Jun N-
terminal kinase ROS signaling (Shin et al., 2010).AUTOPHAGY INDUCING COMPOUNDS IN
MTB INFECTION
The stimulation of autophagy using carbamazepine, rapamycin,
small molecule enhancers of rapamycin (SMERs), specifically
SMERs 18 and 28, as well as vitamin D3 has been shown to
induce Mtb killing in macrophages. In addition, apart from
reducing bacterial burden, carbamazepine has also been shownFebruary 2021 | Volume 10 | Article 618414
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mice with MDR-TB (Floto et al., 2007; Schiebler et al., 2015; Paik
et al., 2019). Using both chemical and RNAi screening,
nortriptyline was revealed to be one of the majorcompounds
that modulate intracellular mycobacteria and was shown to
considerably reduce the survival of intracellular Mtb in
macrophages through the induction of autophagy (Sundaramurthy
et al., 2013). Nitazoxanide (antiprotozoan drug) and flubendazole
(antihelminthic drug) were revealed to activate autophagy to limit
both bacterial and HIV infections in macrophages (Lam et al., 2012;
Chauhan et al., 2015a).
Trehalose has also been reported to induce bacterial killing by
activating autophagy and xenophagy in Mtb infected
macrophages (Sharma et al., 2017). In addition, trehalose has
also been shown to be effective againstan HIV and Mtb co-
infection and regulates the survival ofMtb by overriding the HIV
mediated blockade of autophagy (Sharma et al., 2017). Vitamin
D3 was also shown to induce autophagy to facilitate the killing of
Mtb amidst an HIV co-infection (Campbell and Spector, 2012).
Various host factors have been studied as potential anti-Mtb
therapeutics and have been reported to regulate autophagy and
xenophagy in host cells. For example, the compound saracatinib
(AZD0530) was revealed to induce autophagy and lysosomal
maturation to facilitate the killing of Mtb through inhibiting the
Src kinase in host cells (Chandra et al., 2016a; Chandra
et al., 2016b).
Fluoxetine, a selective serotonin re-uptake inhibitor, has been
shown to induce autophagy to restrict the survival of intracellular
Mtb, possibly by increasing the secretion of TNF-a in Mtb
infected macrophages. Baicalin also induces anti-inflammatory
and antimicrobial activity against Mtb infection, by activating
autophagy through the PI3K/Akt/mTOR pathway in host cells
(Paik et al., 2019). Antimycobacterial agents; loperamide and
verapamil, have been revealed to induce autophagy, to facilitate
the inhibition of intracellular Mtb survival in murine alveolar
macrophages. Ambroxol has also been shown to induce
autophagy in vitro and in vivo, resulting in the killing of Mtb
in murine macrophages (Paik et al., 2019) Table 1.
In addition, the interaction of zymosan with macrophage
TLRs or the FcgRs during phagocytosis has been shown to
promote the recruitment of the LC3 autophagy protein toFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 15phagosomes. Both TLRs and FcgRs activate NOX2 NADPH
oxidase, which is known to induce the production of reactive
oxygen species (ROS). NOX2-dependent ROS production has
been shown to either induce or aid in LC3 recruitment to
phagosomes, thus promoting phagosome maturation and
ultimately microbial killing (Huang et al., 2009; Yang
et al., 2012).NANOTECHNOLOGY APPROACHES
IN HDT-TB
In this decade, NPs have received significant attention in disease
therapy (Mallakpour, 2016). NPs are defined as engineered
particles with a size range typically of 1–100 nm and also up to
1000 nm (Nagavarma et al., 2012). NPs can be classified into
various categories as either organic (e.g. liposomes, polymeric
NPs, lipid NPs or dendrimers), metallic (iron oxide Nps, gold
NPs (GNPs), silver NPs, quantum dots) or ceramic (silica NPs,
calcium carbonate NPs). The application of NPs toward drug
delivery and diagnostics is known as nanomedicine. As drug
delivery systems, drugs can either be encapsulated within the
NP or covalently attached onto the surface of the NP (Figure 8).
By so doing, the properties of these drugs can be improved, e.g.
the aqeous solubility, chemical stability and translocation across
biological barriers. The release of the drugs can also be controlled
to occur over a desired time course or to occur at target sites
following an external trigger (e.g. pH orenzymatic action) thus
modulating plasma and intracellular pharmacokinetics of the
drugs (Dube et al., 2013). Cells also take up NPs more efficiently
making NPs a more auspicious transport and delivery system
(Nasiruddin et al., 2017).
NPs have been observed to induce ROS production in various
cell types (Yu et al., 2014; Chiu et al., 2015; Guo et al., 2015).
Spherical silica NPs of 60 nm in size were shown to stimulate
ROS generation in (HepG2) cells at a final concentration of
100 mg/ml (Yu et al., 2014). Amine-modified but not pristine
or carboxylate modified 60 nm polystyrene spheres were also
observed to induce the generation of ROS in both BEAS-2B lung
epithelial cells and RAW264.7 macrophages atconcentrations
of 20 mg/ml. The amine-modified spheres also induced anTABLE 1 | List of some known authophagy inducing compounds and their applications in TB treatment.
AICs Mechanism of action References
Carbamazepine Neutralization of TNF-a activity (Schiebler et al., 2015)
Vitamin D3 Upregulation of the expression of Atg5 and Beclin-1. Plus, stimulation of the production of CAMP, DEFB4,
reactive oxygen and nitrogen intermediates.




Induction of autophagosome formation by activating Atg5. (Floto et al., 2007)
Rapamycin Inhibition of the activity TOR proteins (e.g. mTOR in mammals). (Floto et al., 2007)
Baicalin Activation of the PI3K/Akt/mTOR pathway and inhibition of the PI3K/Akt/NF-kB signal pathway. (Zhang et al., 2017)
AZD0530 Inhibition of Src kinase activity. (Chandra et al., 2016a; Chandra
et al., 2016b)
Fluoxetine Increase the production of TNF-a. (Stanley et al., 2014)
Ambroxol Activate of Atg5 (possibly). (Choi et al., 2018)
loperamide Reduction of TNF-a production and p62 degradation. (Juárez et al., 2016)
Trehalose Activation of PIKFYVE resulting in TFEB nuclear translocation in a MCOLN1-dependent manner. (Sharma et al., 2020)February 2021 | Volume 10 | Article 618414
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RAW264.7 macrophages were observed to use phagocytic
pathways to take up elongated pristine iron oxide nanorods
(1000 nm × 100 nm), which are then distributed in the cytosol by
autophagosome-like vacuoles 24h post exposure to cells (Park
et al., 2014). Other studies have revealed that these nanorods also
induce an increase in ROS and nitrous oxidelevels in RAW264.7
macrophages. In addition, the nanorods also induced an increase
in the expression levels of Atg5, Beclin1, Erk, p62, and LC3-II,
while reducing JNK phosphorylation levels in the same cell line
(Xia et al., 1995; Nordstrom et al., 2009).
GNPs of size 5 and 13 nm were observed to enhance ROS
production in hypoxic HK-2 cells and increase autophagy in
hypoxic cells. To study the relationship between apoptosis and
autophagy, 3-methyladenine (3-MA), a well-known autophagy
inhibitor was used. 3-MA significantly inhibited the GNP
induced autophagy as expected. However, this treatment
resulted in a 36% reduction in the viability and a 29%
enhancement in the apoptosis of GNP treated cells under
normoxic conditions. On the other hand, exposure to GNPs
resulted in 61% increase in viability and a 52% decrease in the
apoptosis of in HK-2 cells under hypoxic conditions (Ding
et al., 2014).
Silica NPs at 500 mg/ml, were observed to induce the highest
TNF-a release RAW264.7 macrophages, followed by poly(lactic-
co-glycolic acid) (PLGA) NPs which induced the release of
significantly lower TNF-a and finally, silk NPswhich induced
the lowest release of TNF-a in RAW264.7 macrophagesFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 16(Saborano et al., 2017). Unloaded Eudragit® RS NPs have been
observed to be cytotoxic to NR8383 rat macrophages exposed to
doses varying from 15 - 100 µg/mL, the internalized NPs were
also shown to reach and alter the structure of the mitochondria.
In addition, exposure to the NPs also triggered an increase in
ROS production and autophagy in the macrophages (Eidi
et al., 2012).
Particulate b-glucans (WGP) derived from the yeast
Sacchromyces cerevisiae have also been shown to induce LC3
recruitment by increasing LC3-II expression. Formation of an
autophagosome in WGP-induced DCs was also detected,
indicating that the binding of WGP to dectin-1 in DCs,
triggers both autophagy and LC3-associated phagocytosis. In
addition, autophagy induced TNF-a production in WGP treated
DCs, but had no influence on the secretion of IL-12, suggesting
that the maturation of autophagy induced DCs may be archived
using a unique pathway. Furthermore, the WGP also reduced
iNOS expression in autophagy deficient DCs. WGP treated DCs
also induced greater proliferation in CD4 +T-cells when
compared to autophagy deficient DCs (Ding et al., 2019).
In a study demonstrating autophagy in Mtb infected
macrophages (HDT-TB), Upadhyay et al. (2019) reported the
capacity of yeast derived glucan particles (GP) loaded with high
payload of rifabutin (RB) NPs [(RB-NPs)-GP] to induce anti-
mycobacterial and cellular activation responses in Mtb infected
J774 macrophage cells. The exposure to (RB-NPs)-GP was
observed to trigger strong innate immune responses in Mtb
infected macrophages including the induction of apoptosis,FIGURE 8 | A diagram for autophagy inducing nanomedicine. The nanomedicine can be formulated in a variety of ways, the AIC can be encapsulated on the inside
of a nanoparticle and released at the target site using a ligand to target the delivery nanosystem into the target cells. The AIC can also be conjugated on the surface
of the nanoparticle and used to target the AIC to the target cells using receptor recognition. The AIC can stimulate autophagy via receptor stimulation or the AIC can
stimulate specific autophagy pathways after being taken up by the cells.February 2021 | Volume 10 | Article 618414
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addition, the (RB-NPs)-GP formulation was found to induce a
2.5 fold increase in the efficacy of the RB drug (Upadhyay et al.,
2019). However, additional investigations in vivo as well as
studies to target and deliver known AICs are required.CONCLUSION AND FUTURE DIRECTIONS
The interaction between Mtb and the host immunity has been
shown to determine the outcome of the infection. The innate
defense mechanisms of the host play a pivotal role in the process.
An overlap was observed between the pathways that induce
apoptosis and autophagy, for example Mtb has been shown to
stimulate the production of TNF in Mtb infected macrophages
through the TLR2-mediated signaling pathway. In turn, the
induction of TNF-a activity leads to apoptosis in Mtb infected
cell. On the other hand, the production of TNF-a has also been
shown to be vital in the instigation of autophagy against Mtb
infection. In addition, TRL2 has also been shown to induce
mitochondrial ROS in infected macrophages resulting in both
apoptosis and/or autophagy.
Nonetheless,Mtb has developed various mechanisms to evade
the host’s protective immunity and the increase of Mtb’s
resistance to a variety of existing antibiotics has become a
threat to public health across the world. Therefore, the
requirement for new therapeutic strategies has become a key
priority. A promising approach is the use of AICs as part of
HDT. This strategy can be coupled with nanotechnology, to
improve the delivery of these compounds or to synthesize novel
nanosized HDT-TB therapeutics, as studies have revealed that
various NPs can induce autophagy in a variety of cell types. In
addition, the introduction of NPs to HDT-TB can allow for
targeted drug delivery, therefore minimizing the toxic side
effects, while increasing the amount of the drugs that reach
target cells.
However, despite the wide array of available AICs and NPs,
there remains a very limited amount of research regarding the
application of AICs and therapeutic NPs against Mtb.
Mechanistic aspects of the macrophage response to Mtb and
its suppression of autophagy, could be exploited to rationallyFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 17design nanomedicines against this infection. The efficacy of
nanomedicines to eradicate intracellular Mtb within the
granuloma structureis also yet to be investigated. Macrophages
have typically been the target in TB immunotherapy, however,
DCs should also be targeted, as they are the bridge between the
innate and adaptive immunity and can therefore be targeted for
the purpose of both vaccination and therapy. The use of animal
models is also required to determine efficacy of NP HDT in pre-
clinical studies. Toxicity of the selected NPs is also a key concern
and thus, we advocate for the use of biodegradable NPs as they
have been shown to have minimum toxicity in vitro. Ultimately,
we predict that greater understanding of both TB pathogenesis
and the mode of action of AICs will reveal greater insights
toward designing a superior treatment strategy against Mtb
infections in the future.AUTHOR CONTRIBUTIONS
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Juárez, E., Carranza, C., Sánchez, G., González, M., Chávez, J., Sarabia, C., et al.
(2016). Loperamide Restricts Intracellular Growth of Mycobacterium
tuberculosis in Lung Macrophages. Am. J. Respir. Cell Mol. Biol. 55, 837–
847. doi: 10.1165/rcmb.2015-0383OC
Kang, P. B., Azad, A. K., Torrelles, J. B., Kaufman, T. M., Beharka, A., Tibesar, E.,
et al. (2005). The human macrophage mannose receptor directs
Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome
biogenesis. J. Exp. Med. 202, 987–999. doi: 10.1084/jem.20051239
Kasmapour, B., Gronow, A., Bleck, C. K., Hong, W., and Gutierrez, M. G. (2012).
Size-dependent mechanism of cargo sorting during lysosome-phagosome
fusion is controlled by Rab34. Proc. Natl. Acad. Sci. U.S.A. 109, 20485–
20490. doi: 10.1073/pnas.1206811109
Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S., and Bartenschlager, R. (2018).
Host-directed therapies for bacterial and viral infections. Nat. Rev. Drug
Discovery 17, 35–56. doi: 10.1038/nrd.2017.162
Kim, J. S., He, L., and Lemasters, J. J. (2003). Mitochondrial permeability
transition: a common pathway to necrosis and apoptosis. Biochem. Biophys.
Res. Commun. 304, 463–470. doi: 10.1016/S0006-291X(03)00618-1
Kim, B. H., Shenoy, A. R., Kumar, P., Das, R., Tiwari, S., and Macmicking, J. D.
(2011). A family of IFN-gamma-inducible 65-kD GTPases protects against
bacterial infection. Science 332, 717–721. doi: 10.1126/science.1201711
Kim, K. H., An, D. R., Song, J., Yoon, J. Y., Kim, H. S., Yoon, H. J., et al. (2012).
Mycobacterium tuberculosis Eis protein initiates suppression of host immune
responses by acetylation of DUSP16/MKP-7. Proc. Natl. Acad. Sci. U.S.A. 109,
7729–7734. doi: 10.2210/pdb3sxo/pdb
Kim, J. K., Lee, H. M., Park, K. S., Shin, D. M., Kim, T. S., Kim, Y. S., et al. (2017).
MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis
in human monocytes and macrophages by targeting the autophagy protein
DRAM2. Autophagy 13, 423–441. doi: 10.1080/15548627.2016.1241922
Kimmey, J. M., and Stallings, C. L. (2016). Bacterial Pathogens versus Autophagy:
Implications for Therapeutic Interventions. Trends Mol. Med. 22, 1060–1076.
doi: 10.1016/j.molmed.2016.10.008
Kimmey, J. M., Huynh, J. P., Weiss, L. A., Park, S., Kambal, A., Debnath, J., et al.
(2015). Unique role for ATG5 in neutrophil-mediated immunopathology
during M. tuberculosis infection. Nature 528, 565–569. doi: 10.1038/
nature16451
Kimura, T., Jain, A., Choi, S. W., Mandell, M. A., Schroder, K., Johansen, T., et al.
(2015). TRIM-mediated precision autophagy targets cytoplasmic regulators of
innate immunity. J. Cell Biol. 210, 973–989. doi: 10.1083/jcb.201503023
Kolloli, A., and Subbian, S. (2017). Host-Directed Therapeutic Strategies for
Tuberculosis. Front. Med. (Lausanne) 4, 171. doi: 10.3389/fmed.2017.00171
Koster, S., Upadhyay, S., Chandra, P., Papavinasasundaram, K., Yang, G., Hassan, A.,
et al. (2017). Mycobacterium tuberculosis is protected from NADPH oxidase and
LC3-associated phagocytosis by the LCP protein CpsA. Proc. Natl. Acad. Sci.
U.S.A. 114, E8711–e8720. doi: 10.1073/pnas.1707792114
Kumar, M., Sahu, S. K., Kumar, R., Subuddhi, A., Maji, R. K., Jana, K., et al. (2015).
MicroRNA let-7 modulates the immune response to Mycobacterium
tuberculosis infection via control of A20, an inhibitor of the NF-kappaB
pathway. Cell Host Microbe 17, 345–356. doi: 10.1016/j.chom.2015.01.007
Kumar, R., Sahu, S. K., Kumar, M., Jana, K., Gupta, P., Gupta, U. D., et al. (2016).
MicroRNA 17-5p regulates autophagy in Mycobacterium tuberculosis-infected
macrophages by targeting Mcl-1 and STAT3. Cell Microbiol. 18, 679–691. doi:
10.1111/cmi.12540
Kurtz, S., Mckinnon, K. P., Runge, M. S., Ting, J. P., and Braunstein, M. (2006).
The SecA2 secretion factor of Mycobacterium tuberculosis promotes growth in
macrophages and inhibits the host immune response. Infect. Immun. 74, 6855–
6864. doi: 10.1128/IAI.01022-06
Lam, K. K., Zheng, X., Forestieri, R., Balgi, A. D., Nodwell, M., Vollett, S., et al.
(2012). Nitazoxanide stimulates autophagy and inhibits mTORC1 signalingFebruary 2021 | Volume 10 | Article 618414
Maphasa et al. Inducing Autophagy for TB Treatmentand intracellular proliferation of Mycobacterium tuberculosis. PloS Pathog. 8,
e1002691. doi: 10.1371/journal.ppat.1002691
Lam, A., Prabhu, R., Gross, C. M., Riesenberg, L. A., Singh, V., and Aggarwal, S.
(2017). Role of apoptosis and autophagy in tuberculosis. Am. J. Physiol. Lung
Cell Mol. Physiol. 313, L218–l229. doi: 10.1152/ajplung.00162.2017
Lamichhane, G. (2011). Mycobacterium tuberculosis response to stress from
reactive oxygen and nitrogen species. Front. Microbiol. 2, 176. doi: 10.3389/
fmicb.2011.00176
Lammas, D. A., Stober, C., Harvey, C. J., Kendrick, N., Panchalingam, S., and
Kumararatne, D. S. (1997). ATP-induced killing of mycobacteria by human
macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 7,
433–444. doi: 10.1016/S1074-7613(00)80364-7
Lancellotti, M., Brocchi, M., and Dias Da Silveira, W. (2006). Bacteria-induced
apoptosis: An approach to bacterial pathogenesis. Braz. J. Morphol. Sci. 23, 75–86.
Lee, J., Cho, E. C., and Cho, K. (2004). Incorporation and release behavior of
hydrophobic drug in functionalized poly(D,L-lactide)-block-poly(ethylene
oxide) micelles. J. Control Rel. 94, 323–335. doi: 10.1016/j.jconrel.2003.10.012
Lee, J., Hartman, M., and Kornfeld, H. (2009). Macrophage apoptosis in
tuberculosis. Yonsei Med. J. 50, 1–11. doi: 10.3349/ymj.2009.50.1.1
Ma, J., Becker, C., Lowell, C. A., and Underhill, D. M. (2012). Dectin-1-triggered
recruitment of light chain 3 protein to phagosomes facilitates major
histocompatibility complex class II presentation of fungal-derived antigens.
J. Biol. Chem. 287, 34149–34156. doi: 10.1074/jbc.M112.382812
Ma, J., Yang, B., Yu, S., Zhang, Y., Zhang, X., Lao, S., et al. (2014).
Tuberculosis antigen-induced expression of IFN-alpha in tuberculosis
patients inhibits production of IL-1beta. FASEB J. 28, 3238–3248. doi:
10.1096/fj.13-247056
Macmicking, J. D., Taylor, G. A., and Mckinney, J. D. (2003). Immune control of
tuberculosis by IFN-gamma-inducible LRG-47. Science 302, 654–659. doi:
10.1126/science.1088063
Mallakpour, S. (2016). Polymeric nanoparticles: Recent development in synthesis
and application. Express Polymer. Lett. 10, 895–913. doi: 10.3144/
expresspolymlett.2016.84
Marakalala, M. J., and Ndlovu, H. (2017). Signaling C-type lectin receptors in
antimycobacterial immunity. PloS Pathog. 13, e1006333. doi: 10.1371/
journal.ppat.1006333
Martinez, J., Malireddi, R. K., Lu, Q., Cunha, L. D., Pelletier, S., Gingras, S., et al.
(2015). Molecular characterization of LC3-associated phagocytosis reveals
distinct roles for Rubicon, NOX2 and autophagy proteins. Nat. Cell Biol. 17,
893–906. doi: 10.1038/ncb3192
Martinvalet, D., Dykxhoorn, D. M., Ferrini, R., and Lieberman, J. (2008).
Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-
independent cell death. Cell 133, 681–692. doi: 10.1016/j.cell.2008.03.032
Miller, J. L., Velmurugan, K., Cowan, M. J., and Briken, V. (2010). The type I
NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal
NOX2 activity to inhibit TNF-alpha-mediated host cell apoptosis. PloS Pathog.
6, e1000864. doi: 10.1371/journal.ppat.1000864
Mishra, A., Akhtar, S., Jagannath, C., and Khan, A. (2017). Pattern recognition
receptors and coordinated cellular pathways involved in tuberculosis
immunopathogenesis: Emerging concepts and perspectives. Mol. Immunol.
87, 240–248. doi: 10.1016/j.molimm.2017.05.001
Mitchell, G., and Isberg, R. R. (2017). Innate Immunity to Intracellular Pathogens:
Balancing Microbial Elimination and Inflammation. Cell Host Microbe 22,
166–175. doi: 10.1016/j.chom.2017.07.005
Moreau, K., Lacas-Gervais, S., Fujita, N., Sebbane, F., Yoshimori, T., Simonet, M.,
et al. (2010). Autophagosomes can support Yersinia pseudotuberculosis
replication in macrophages. Cell Microbiol. 12, 1108–1123. doi: 10.1111/
j.1462-5822.2010.01456.x
Mueller, P., and Pieters, J. (2006). Modulation of macrophage antimicrobial
mechanisms by pathogenic mycobacteria. Immunobiology 211, 549–556. doi:
10.1016/j.imbio.2006.06.004
Nagavarma, B. V. N., Yadav, H., Ayaz, A., Vasudha, L., and Shivakumar, H.
(2012). Different techniques for preparation of polymeric nanoparticles- A
review. Asian J. Pharm. Clin. Res. 5, 16–23.
Nasiruddin, M., Neyaz, M. K., and Das, S. (2017). Nanotechnology-Based
Approach in Tuberculosis Treatment. Tuberc. Res. Treat 2017, 4920209. doi:
10.1155/2017/4920209Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 20Nigou, J., Zelle-Rieser, C., Gilleron, M., Thurnher, M., and Puzo, G. (2001).
Mannosylated lipoarabinomannans inhibit IL-12 production by human
dendritic cells: evidence for a negative signal delivered through the mannose
receptor. J. Immunol. 166, 7477–7485. doi: 10.4049/jimmunol.166.12.7477
Nordstrom, E., Fisone, G., and Kristensson, K. (2009). Opposing effects of ERK
and p38-JNK MAP kinase pathways on formation of prions in GT1-1 cells.
FASEB J. 23, 613–622. doi: 10.1096/fj.08-115360
Ouimet, M., Koster, S., Sakowski, E., Ramkhelawon, B., Van Solingen, C.,
Oldebeken, S., et al. (2016). Mycobacterium tuberculosis induces the miR-33
locus to reprogram autophagy and host lipid metabolism. Nat. Immunol. 17,
677–686. doi: 10.1038/ni.3434
Paik, S., Kim, J. K., Chung, C., and Jo, E. K. (2019). Autophagy: A new strategy for
host-directed therapy of tuberculosis. Virulence 10, 448–459. doi: 10.1080/
21505594.2018.1536598
Park, E. J., Umh, H. N., Kim, S. W., Cho, M. H., Kim, J. H., and Kim, Y. (2014).
ERK pathway is activated in bare-FeNPs-induced autophagy. Arch. Toxicol. 88,
323–336. doi: 10.1007/s00204-013-1134-1
Pastore, N., Brady, O. A., Diab, H.II, Martina, J. A., Sun, L., Huynh, T., et al.
(2016). TFEB and TFE3 cooperate in the regulation of the innate immune
response in activated macrophages. Autophagy 12, 1240–1258. doi: 10.1080/
15548627.2016.1179405
Petruccioli, E., Romagnoli, A., Corazzari, M., Coccia, E. M., Butera, O., Delogu, G.,
et al. (2012). Specific T cells restore the autophagic flux inhibited by
Mycobacterium tuberculosis in human primary macrophages. J. Infect. Dis.
205, 1425–1435. doi: 10.1093/infdis/jis226
Pozzi, L. A., Maciaszek, J. W., and Rock, K. L. (2005). Both dendritic cells and
macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop
effector function, and differentiate into memory cells. J. Immunol. 175, 2071–
2081. doi: 10.4049/jimmunol.175.4.2071
Prashar, A., Schnettger, L., Bernard, E. M., and Gutierrez, M. G. (2017). Rab
GTPases in Immunity and Inflammation. Front. Cell Infect. Microbiol. 7, 435.
doi: 10.3389/fcimb.2017.00435
Pu, Q., Gan, C., Li, R., Li, Y., Tan, S., Li, X., et al. (2017). Atg7 Deficiency Intensifies
Inflammasome Activation and Pyroptosis in Pseudomonas Sepsis. J. Immunol.
198, 3205–3213. doi: 10.4049/jimmunol.1601196
Pujol, C., Klein, K. A., Romanov, G. A., Palmer, L. E., Cirota, C., Zhao, Z., et al.
(2009). Yersinia pestis can reside in autophagosomes and avoid xenophagy in
murine macrophages by preventing vacuole acidification. Infect. Immun. 77,
2251–2261. doi: 10.1128/IAI.00068-09
Quesniaux, V., Fremond, C., Jacobs, M., Parida, S., Nicolle, D., Yeremeev, V., et al.
(2004). Toll-like receptor pathways in the immune responses to mycobacteria.
Microbes Infect. 6, 946–959. doi: 10.1016/j.micinf.2004.04.016
Queval, C. J., Brosch, R., and Simeone, R. (2017). The Macrophage: A Disputed
Fortress in the Battle against Mycobacterium tuberculosis. Front. Microbiol. 8,
2284. doi: 10.3389/fmicb.2017.02284
Ricci, J. E., Muñoz-Pinedo, C., Fitzgerald, P., Bailly-Maitre, B., Perkins, G. A.,
Yadava, N., et al. (2004). Disruption of mitochondrial function during
apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of
the electron transport chain. Cell 117, 773–786. doi: 10.1016/j.cell.2004.05.008
Rohde, K., Yates, R. M., Purdy, G. E., and Russell, D. G. (2007). Mycobacterium
tuberculosis and the environment within the phagosome. Immunol. Rev. 219,
37–54. doi: 10.1111/j.1600-065X.2007.00547.x
Romagnoli, A., Etna, M. P., Giacomini, E., Pardini, M., Remoli, M. E., Corazzari, M.,
et al. (2012). ESX-1 dependent impairment of autophagic flux byMycobacterium
tuberculosis in human dendritic cells. Autophagy 8, 1357–1370. doi: 10.4161/
auto.20881
Romao, S., Gasser, N., Becker, A. C., Guhl, B., Bajagic, M., Vanoaica, D., et al.
(2013). Autophagy proteins stabilize pathogen-containing phagosomes for
prolonged MHC II antigen processing. J. Cell Biol. 203, 757–766. doi:
10.1083/jcb.201308173
Russell, D. G., Cardona, P. J., Kim, M. J., Allain, S., and Altare, F. (2009). Foamy
macrophages and the progression of the human tuberculosis granuloma. Nat.
Immunol. 10, 943–948. doi: 10.1038/ni.1781
Saborano, R., Wongpinyochit, T., Totten, J. D., Johnston, B. F., Seib, F. P., and
Duarte, I. F. (2017). Metabolic Reprogramming of Macrophages Exposed to
Silk, Poly(lactic-co-glycolic acid), and Silica Nanoparticles. Adv. Healthc.
Mater. 6, 1–13. doi: 10.1002/adhm.201601240February 2021 | Volume 10 | Article 618414
Maphasa et al. Inducing Autophagy for TB TreatmentSaitoh, T., and Akira, S. (2016). Regulation of inflammasomes by autophagy.
J. Allergy Clin. Immunol. 138, 28–36. doi: 10.1016/j.jaci.2016.05.009
Sakowski, E. T., Koster, S., Portal Celhay, C., Park, H. S., Shrestha, E., Hetzenecker,
S. E., et al. (2015). Ubiquilin 1 Promotes IFN-gamma-Induced Xenophagy of
Mycobacterium tuberculosis. PloS Pathog. 11, e1005076. doi: 10.1371/
journal.ppat.1005076
Salgame, P. (2005). Host innate and Th1 responses and the bacterial factors that
control Mycobacterium tuberculosis infection. Curr. Opin. Immunol. 17, 374–
380. doi: 10.1016/j.coi.2005.06.006
Samuel, L. P., Song, C. H., Wei, J., Roberts, E. A., Dahl, J. L., Barry, C. E., et al.
(2007). Expression, production and release of the Eis protein by
Mycobacterium tuberculosis during infection of macrophages and its effect
on cytokine secretion. Microbiology 153, 529–540. doi: 10.1099/mic.0.2006/
002642-0
Sanjuan, M. A., Dillon, C. P., Tait, S. W., Moshiach, S., Dorsey, F., Connell, S., et al.
(2007). Toll-like receptor signalling in macrophages links the autophagy
pathway to phagocytosis. Nature 450, 1253–1257. doi: 10.1038/nature06421
Sarathy, J., Dartois, V., Dick, T., and Gengenbacher, M. (2013a). Reduced drug
uptake in phenotypically resistant nutrient-starved nonreplicating
Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 57, 1648–1653.
doi: 10.1128/AAC.02202-12
Sarathy, J. P., Lee, E., and Dartois, V. (2013b). Polyamines inhibit porin-mediated
fluoroquinolone uptake in mycobacteria. PloS One 8, e65806. doi: 10.1371/
journal.pone.0065806
Schiebler, M., Brown, K., Hegyi, K., Newton, S. M., Renna, M., Hepburn, L., et al.
(2015). Functional drug screening reveals anticonvulsants as enhancers of
mTOR-independent autophagic killing of Mycobacterium tuberculosis
through inositol depletion. EMBO Mol. Med. 7, 127–139. doi: 10.15252/
emmm.201404137
Schnettger, L., Rodgers, A., Repnik, U., Lai, R. P., Pei, G., Verdoes, M., et al. (2017).
A Rab20-Dependent Membrane Trafficking Pathway Controls M. tuberculosis
Replication by Regulating Phagosome Spaciousness and Integrity. Cell Host
Microbe 21, 619–628.e5. doi: 10.1016/j.chom.2017.04.004
Schüler, P., Zemper, K., Borner, K., Koeppe, P., Schaberg, T., and Lode, H. (1997).
Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages,
epithelial lining fluid, and polymorphonuclear leucocytes. Eur. Respir. J. 10,
1130–1136. doi: 10.1183/09031936.97.10051130
Schuller, S., Neefjes, J., Ottenhoff, T., Thole, J., and Young, D. (2001). Coronin is
involved in uptake of Mycobacterium bovis BCG in human macrophages but
not in phagosome maintenance. Cell Microbiol. 3, 785–793. doi: 10.1046/
j.1462-5822.2001.00155.x
Sharma, V., Makhdoomi, M., Kumar, P., Khan, N., Singh, S., Verma, H. N., et al.
(2017). Induction of autophagy by trehalose limits opportunistic mycobacterial
infections in HIV-infected macrophages. bioRxiv 1, 202697. doi: 10.1101/
202697
Sharma, V., Makhdoomi, M., Singh, L., Kumar, P., Khan, N., Singh, S., et al.
(2020). Trehalose limits opportunistic mycobacterial survival during HIV co-
infection by reversing HIV-mediated autophagy block. Autophagy, 1–20. doi:
10.1080/15548627.2020.1725374
Shi, C. S., and Kehrl, J. H. (2010). TRAF6 and A20 regulate lysine 63-linked
ubiquitination of Beclin-1 to control TLR4-induced autophagy. Sci. Signal 3,
ra42. doi: 10.1126/scisignal.2000751
Shi, C. S., Shenderov, K., Huang, N. N., Kabat, J., Abu-Asab, M., Fitzgerald, K. A.,
et al. (2012). Activation of autophagy by inflammatory signals limits IL-1beta
production by targeting ubiquitinated inflammasomes for destruction. Nat.
Immunol. 13, 255–263. doi: 10.1038/ni.2215
Shibutani, S. T., Saitoh, T., Nowag, H., Munz, C., and Yoshimori, T. (2015).
Autophagy and autophagy-related proteins in the immune system. Nat.
Immunol. 16, 1014–1024. doi: 10.1038/ni.3273
Shin, D. M., Jeon, B. Y., Lee, H. M., Jin, H. S., Yuk, J. M., Song, C. H., et al. (2010).
Mycobacterium tuberculosis eis regulates autophagy, inflammation, and cell
death through redox-dependent signaling. PloS Pathog. 6, e1001230. doi:
10.1371/journal.ppat.1001230
Silva Miranda, M., Breiman, A., Allain, S., Deknuydt, F., and Altare, F. (2012). The
tuberculous granuloma: an unsuccessful host defence mechanism providing a
safety shelter for the bacteria? Clin. Dev. Immunol. 2012, 139127. doi: 10.1155/
2012/139127Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 21Soman, A., Honeybourne, D., Andrews, J., Jevons, G., and WISE, R. (1999).
Concentrations of moxifloxacin in serum and pulmonary compartments
following a single 400 mg oral dose in patients undergoing fibre-optic
bronchoscopy. J. Antimicrob. Chemother. 44, 835–838. doi: 10.1093/jac/
44.6.835
Songane, M., Kleinnijenhuis, J., Netea, M. G., and Van Crevel, R. (2012). The role
of autophagy in host defence against Mycobacterium tuberculosis infection.
Tuberculosis (Edinb.) 92, 388–396. doi: 10.1016/j.tube.2012.05.004
Stanley, S. A., Barczak, A. K., Silvis, M. R., Luo, S. S., Sogi, K., Vokes, M., et al.
(2014). Identification of Host-Targeted Small Molecules That Restrict
Intracellular Mycobacterium tuberculosis Growth. PloS Pathog. 10,
e1003946. doi: 10.1371/journal.ppat.1003946
Sundaramurthy, V., Barsacchi, R., Samusik, N., Marsico, G., Gilleron, J.,
Kalaidzidis, I. , et al. (2013). Integration of chemical and RNAi
mu l t ip a rame t r i c p rofi l e s i den t ifi e s t r i gge r s o f in t r ac e l l u l a r
mycobacterial killing. Cell Host Microbe 13, 129–142. doi: 10.1016/
j.chom.2013.01.008
Sun-Wada, G. H., Tabata, H., Kawamura, N., Aoyama, M., and Wada, Y. (2009).
Direct recruitment of H+-ATPase from lysosomes for phagosomal
acidification. J. Cell Sci. 122, 2504–2513. doi: 10.1242/jcs.050443
Tailleux, L., Schwartz, O., Herrmann, J. L., Pivert, E., Jackson, M., Amara, A., et al.
(2003). DC-SIGN is the major Mycobacterium tuberculosis receptor on human
dendritic cells. J. Exp. Med. 197, 121–127. doi: 10.1084/jem.20021468
Tanne, A., and Neyrolles, O. (2010). C-type lectins in immune defense against
pathogens: the murine DC-SIGN homologue SIGNR3 confers early protection
against Mycobacterium tuberculosis infection. Virulence 1, 285–290. doi:
10.4161/viru.1.4.11967
Toyonaga, K., Torigoe, S., Motomura, Y., Kamichi, T., Hayashi, J. M., Morita,
Y. S. , et al. (2016). C-Type Lectin Receptor DCAR Recognizes
Mycobacterial Phosphatidyl-Inositol Mannosides to Promote a Th1
Response during Infection. Immunity 45, 1245–1257. doi: 10.1016/
j.immuni.2016.10.012
Tukulula, M., Gouveia, L., Paixao, P., Hayeshi, R., Naicker, B., and Dube, A.
(2018). Functionalization of PLGA Nanoparticles with 1,3-b-glucan Enhances
the Intracellular Pharmacokinetics of Rifampicin in Macrophages. Pharm. Res.
35, 111. doi: 10.1007/s11095-018-2391-8
Upadhyay, T. K., Fatima, N., Sharma, A., Sharma, D., and Sharma, R. (2019).
Nano-Rifabutin entrapment within glucan microparticles enhances protection
against intracellular Mycobacterium tuberculosis. Artif. Cells Nanomed.
Biotechnol. 47, 427–435. doi: 10.1080/21691401.2018.1559180
Van Crevel, R., Ottenhoff, T. H. M., and Van Der Meer, J. W. M. (2002). Innate
Immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 15, 294. doi:
10.1128/CMR.15.2.294-309.2002
Van De Veerdonk, F. L., Teirlinck, A. C., Kleinnijenhuis, J., Kullberg, B. J., Van
Crevel, R., Van Der Meer, J. W., et al. (2010). Mycobacterium tuberculosis
induces IL-17A responses through TLR4 and dectin-1 and is critically
dependent on endogenous IL-1. J. Leukoc. Biol. 88, 227–232. doi: 10.1189/
jlb.0809550
Van Der Vaart, M., Korbee, C. J., Lamers, G. E., Tengeler, A. C., Hosseini, R., Haks,
M. C., et al. (2014). The DNA damage-regulated autophagy modulator
DRAM1 links mycobacterial recognition via TLR-MYD88 to autophagic
defense [corrected]. Cell Host Microbe 15, 753–767. doi: 10.1016/
j.chom.2014.05.005
Vandenabeele, P., Declercq, W., Van Herreweghe, F., and Vanden Berghe, T.
(2010). The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci.
Signal 3, re4. doi: 10.1126/scisignal.3115re4
Vazquez, C. L., Rodgers, A., Herbst, S., Coade, S., Gronow, A., Guzman, C. A., et al.
(2016). The proneurotrophin receptor sortilin is required for Mycobacterium
tuberculosis control by macrophages. Sci. Rep. 6, 29332. doi: 10.1038/
srep29332
Vergne, I., Chua, J., and Deretic, V. (2003). Tuberculosis toxin blocking
phagosome maturation inhibits a novel Ca2+/calmodulin-PI3K hVPS34
cascade. J. Exp. Med. 198, 653–659. doi: 10.1084/jem.20030527
Vieira, O. V., Botelho, R. J., and Grinstein, S. (2002). Phagosome maturation: aging
gracefully. Biochem. J. 366, 689–704. doi: 10.1042/bj20020691
Villeneuve, C., Gilleron, M., Maridonneau-Parini, I., Daffe, M., Astarie-Dequeker, C.,
and Etienne, G. (2005). Mycobacteria use their surface-exposed glycolipids toFebruary 2021 | Volume 10 | Article 618414
Maphasa et al. Inducing Autophagy for TB Treatmentinfect human macrophages through a receptor-dependent process. J. Lipid Res.
46, 475–483. doi: 10.1194/jlr.M400308-JLR200
Walburger, A., Koul, A., Ferrari, G., Nguyen, L., Prescianotto-Baschong, C., Huygen, K.,
et al. (2004). Protein kinase G from pathogenic mycobacteria promotes survival
within macrophages. Science 304, 1800–1804. doi: 10.1126/science.1099384
Wang, Z., Jiang, H., Chen, S., Du, F., and Wang, X. (2012). The mitochondrial
phosphatase PGAM5 functions at the convergence point of multiple necrotic
death pathways. Cell 148, 228–243. doi: 10.1016/j.cell.2011.11.030
Watson, R. O., Manzanillo, P. S., and Cox, J. S. (2012). Extracellular M.
tuberculosis DNA targets bacteria for autophagy by activating the host
DNA-sensing pathway. Cell 150, 803–815. doi: 10.1016/j.cell.2012.06.040
Watson, R. O., Bell, S. L., Macduff, D. A., Kimmey, J. M., Diner, E. J., Olivas, J.,
et al. (2015). The Cytosolic Sensor cGAS Detects Mycobacterium tuberculosis
DNA to Induce Type I Interferons and Activate Autophagy. Cell Host Microbe
17, 811–819. doi: 10.1016/j.chom.2015.05.004
Winau, F., Weber, S., Sad, S., De Diego, J., Hoops, S. L., Breiden, B., et al. (2006).
Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis.
Immunity 24, 105–117. doi: 10.1016/j.immuni.2005.12.001
Wong, D., Chao, J. D., and Av-Gay, Y. (2013). Mycobacterium tuberculosis-
secreted phosphatases: from pathogenesis to targets for TB drug development.
Trends Microbiol. 21, 100–109. doi: 10.1016/j.tim.2012.09.002
World Health Organization (2018). Global Tuberculosis Report 2018 (Geneva:
World Health Organization).
World Health Organization (2019). Global Tuberculosis Report 2019 (Geneva:
World Health Organization).
Wu, Y., Wang, Y., Zou, H., Wang, B., Sun, Q., Fu, A., et al. (2017). Probiotic Bacillus
amyloliquefaciens SC06 Induces Autophagy to Protect against Pathogens in
Macrophages. Front. Microbiol. 8, 469. doi: 10.3389/fmicb.2017.00469
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. (1995).
Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270,
1326–1331. doi: 10.1126/science.270.5240.1326
Xu, G., Wang, J., Gao, G. F., and Liu, C. H. (2014). Insights into battles between
Mycobacterium tuberculosis and macrophages. Protein Cell 5, 728–736. doi:
10.1007/s13238-014-0077-5
Yang, C. S., Lee, J. S., Rodgers, M., Min, C. K., Lee, J. Y., Kim, H. J., et al. (2012).
Autophagy protein Rubicon mediates phagocytic NADPH oxidase activationFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 22in response to microbial infection or TLR stimulation. Cell Host Microbe 11,
264–276. doi: 10.1016/j.chom.2012.01.018
Yasir, M., Pachikara, N. D., Bao, X., Pan, Z., and Fan, H. (2011). Regulation of
chlamydial infection by host autophagy and vacuolar ATPase-bearing
organelles. Infect. Immun. 79, 4019–4028. doi: 10.1128/IAI.05308-11
Yonekawa, A., Saijo, S., Hoshino, Y., Miyake, Y., Ishikawa, E., Suzukawa, M., et al.
(2014). Dectin-2 is a direct receptor for mannose-capped lipoarabinomannan
of mycobacteria. Immunity 41, 402–413. doi: 10.1016/j.immuni.2014.08.005
Yu, Y., Duan, J., Yu, Y., Li, Y., Liu, X., Zhou, X., et al. (2014). Silica nanoparticles
induce autophagy and autophagic cell death in HepG2 cells triggered by
reactive oxygen species. J. Hazard. Mater. 270, 176–186. doi: 10.1016/
j.jhazmat.2014.01.028
Yuk, J. M., Shin, D. M., Lee, H. M., Yang, C. S., Jin, H. S., Kim, K. K., et al. (2009).
Vitamin D3 induces autophagy in human monocytes/macrophages via
cathelicidin. Cell Host Microbe 6, 231–243. doi: 10.1016/j.chom.2009.08.004
Zhai, W., Wu, F., Zhang, Y., Fu, Y., and Liu, Z. (2019). The Immune Escape
Mechanisms of Mycobacterium Tuberculosis. Int. J. Mol. Sci. 20, 1–18. doi:
10.3390/ijms20020340
Zhang, Q., Sun, J., Wang, Y., He, W., Wang, L., Zheng, Y., et al. (2017).
Antimycobacterial and Anti-inflammatory Mechanisms of Baicalin via
Induced Autophagy in Macrophages Infected with Mycobacterium
tuberculosis. Front. Microbiol. 8, 2142. doi: 10.3389/fmicb.2017.02142
Zumla, A., Rao, M., Dodoo, E., and Maeurer, M. (2016). Potential of
immunomodulatory agents as adjunct host-directed therapies for multidrug-
resistant tuberculosis. BMC Med. 14, 89. doi: 10.1186/s12916-016-0635-1
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2021 Maphasa, Meyer and Dube. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these terms.February 2021 | Volume 10 | Article 618414
